KEGG Orthology (KO) - Pan troglodytes (chimpanzee)

[ Brite menu | Organism menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level 

     KO
 Metabolism
 
   Overview
 
   Carbohydrate metabolism
 
   Energy metabolism
 
   Lipid metabolism
     00061 Fatty acid biosynthesis [PATH:ptr00061]
     00062 Fatty acid elongation [PATH:ptr00062]
     00071 Fatty acid degradation [PATH:ptr00071]
     00072 Synthesis and degradation of ketone bodies [PATH:ptr00072]
     00073 Cutin, suberine and wax biosynthesis
     00100 Steroid biosynthesis [PATH:ptr00100]
     00120 Primary bile acid biosynthesis [PATH:ptr00120]
     00121 Secondary bile acid biosynthesis
     00140 Steroid hormone biosynthesis [PATH:ptr00140]
     00561 Glycerolipid metabolism [PATH:ptr00561]
     00564 Glycerophospholipid metabolism [PATH:ptr00564]
     00565 Ether lipid metabolism [PATH:ptr00565]
     00600 Sphingolipid metabolism [PATH:ptr00600]
     00590 Arachidonic acid metabolism [PATH:ptr00590]
       748864 PLA2G2E; phospholipase A2, group IIE
       748868 PLA2G2F; phospholipase A2, group IIF
       469200 PLA2G2D; phospholipase A2, group IID
       466292 PLA2G12B; phospholipase A2, group XIIB
       740803 PLA2G10; phospholipase A2, group X
       456587 PLA2G2A; phospholipase A2, group IIA (platelets, synovial fluid)
       456588 PLA2G5; phospholipase A2, group V
       470183 PLA2G3; phospholipase A2, group III
       742280 PLA2G1B; phospholipase A2, group IB (pancreas)
       736845 PLA2G12A; phospholipase A2, group XIIA
       467664 PLA2G4E; phospholipase A2, group IVE
       469617 PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent)
       453706 cytosolic phospholipase A2 beta-like
       747584 PLA2G4B; phospholipase A2, group IVB (cytosolic)
       468935 PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent)
       100610135 PLA2G4D; phospholipase A2, group IVD (cytosolic)
       453356 PLA2G4F; phospholipase A2, group IVF
       739598 PLA2G4B; phospholipase A2, group IVB
       749457 PLA2G4B; phospholipase A2, group IVB
       739798 PLA2G4B; phospholipase A2, group IVB
       740368 PLA2G4B; phospholipase A2, group IVB
       748705 PLA2G4B; phospholipase A2, group IVB
       470208 PLA2G6; phospholipase A2, group VI (cytosolic, calcium-independent)
       459117 PLB1; phospholipase B1
       451279 PLA2G16; phospholipase A2, group XVI
       464713 PTGS1; prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       473071 PTGES; prostaglandin E synthase
       464763 PTGES2; prostaglandin E synthase 2 
       746021 PTGES3; prostaglandin E synthase 3 (cytosolic) 
       473983 CBR1; carbonyl reductase 1
       458533 CBR3; carbonyl reductase 3
       744202 FAM213B; family with sequence similarity 213, member B
       463774 TBXAS1; thromboxane A synthase 1 (platelet)
       743219 HPGDS; hematopoietic prostaglandin D synthase
       749402 PTGDS; prostaglandin D2 synthase 21kDa (brain)
       100612718 AKR1C3; aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)
       458323 PTGIS; prostaglandin I2 (prostacyclin) synthase
       450428 ALOX5; arachidonate 5-lipoxygenase
       452145 LTA4H; leukotriene A4 hydrolase 
       748117 leukotriene-B(4) omega-hydroxylase 2-like
       748531 leukotriene-B(4) omega-hydroxylase 2-like
       739986 LTC4S; leukotriene C4 synthase
       470168 GGT1; gamma-glutamyltransferase 1
       458194 GGT7; gamma-glutamyltransferase 7
       458711 GGT5; gamma-glutamyltransferase 5 
       454447 GGT6; gamma-glutamyltransferase 6
       469325 GPX7; glutathione peroxidase 7 
       461015 GPX1; glutathione peroxidase 1 
       471920 GPX6; glutathione peroxidase 6 (olfactory) 
       471703 GPX3; glutathione peroxidase 3 (plasma) 
       467483 GPX2; glutathione peroxidase 2 (gastrointestinal) 
       461872 GPX8; glutathione peroxidase 8 (putative) 
       450857 cytochrome P450 2E1-like
       456896 cytochrome P450 2J2-like
       471267 cytochrome P450 2U1-like
       739864 cytochrome P450 4A11-like
       740956 cytochrome P450 2C19-like
       748442 cytochrome P450 4F8-like
       455242 ALOX12; arachidonate 12-lipoxygenase
       455243 arachidonate 12-lipoxygenase
       455103 ALOX12B; arachidonate 12-lipoxygenase, 12R type
       455104 ALOX15B; arachidonate 15-lipoxygenase, type B
       456052 cytochrome P450 2B6-like
       450909 CYP2C8; cytochrome P450, family 2, subfamily C, polypeptide 8
       100616515 cytochrome P450 2C9-like
       464074 EPHX2; epoxide hydrolase 2, cytoplasmic
       748294 ALOX15; arachidonate 15-lipoxygenase
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16343 PLA2G6; calcium-independent phospholipase A2 [EC:3.1.1.4]
K14621 PLB1; phospholipase B1, membrane-associated [EC:3.1.1.4 3.1.1.5]
K16817 PLA2G16; HRAS-like suppressor 3 [EC:3.1.1.32 3.1.1.4]
K00509 PTGS1; prostaglandin-endoperoxide synthase 1 [EC:1.14.99.1]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K15729 PTGES; microsomal prostaglandin-E synthase 1 [EC:5.3.99.3]
K05309 PTGES2; microsomal prostaglandin-E synthase 2 [EC:5.3.99.3]
K15730 PTGES3; cytosolic prostaglandin-E synthase [EC:5.3.99.3]
K00079 CBR1; carbonyl reductase 1 [EC:1.1.1.184 1.1.1.189 1.1.1.197]
K00084 CBR3; carbonyl reductase 3 [EC:1.1.1.184]
K15717 K15717; prostamide/prostaglandin F2alpha synthase [EC:1.11.1.20]
K01832 TBXAS1; thromboxane-A synthase [EC:5.3.99.5]
K01830 E5.3.99.2; prostaglandin-H2 D-isomerase [EC:5.3.99.2]
K01830 E5.3.99.2; prostaglandin-H2 D-isomerase [EC:5.3.99.2]
K04119 AKR1C3; aldo-keto reductase family 1 member C3 [EC:1.1.1.64 1.1.1.188 1.1.1.213]
K01831 PTGIS; prostacyclin synthase [EC:5.3.99.4]
K00461 ALOX5; arachidonate 5-lipoxygenase [EC:1.13.11.34]
K01254 LTA4H; leukotriene-A4 hydrolase [EC:3.3.2.6]
K17726 CYP4F2_3; leukotriene-B4 20-monooxygenase / phylloquinone omega-hydroxylase [EC:1.14.13.30 1.14.13.194]
K17726 CYP4F2_3; leukotriene-B4 20-monooxygenase / phylloquinone omega-hydroxylase [EC:1.14.13.30 1.14.13.194]
K00807 LTC4S; leukotriene-C4 synthase [EC:4.4.1.20]
K00681 ggt; gamma-glutamyltranspeptidase [EC:2.3.2.2]
K00681 ggt; gamma-glutamyltranspeptidase [EC:2.3.2.2]
K00681 ggt; gamma-glutamyltranspeptidase [EC:2.3.2.2]
K00681 ggt; gamma-glutamyltranspeptidase [EC:2.3.2.2]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K07415 CYP2E1; cytochrome P450, family 2, subfamily E, polypeptide 1 [EC:1.14.13.-]
K07418 CYP2J; cytochrome P450, family 2, subfamily J [EC:1.14.14.1]
K07422 CYP2U1; cytochrome P450, family 2, subfamily U, polypeptide 1
K07425 CYP4A; alkane 1-monooxygenase [EC:1.14.15.3]
K17721 CYP2C19; cytochrome P450, family 2, subfamily C, polypeptide 19 [EC:1.14.13.48 1.14.13.49 1.14.13.80 1.14.13.-]
K17728 CYP4F8; cytochrome P450, family 4, subfamily F, polypeptide 8 [EC:1.14.14.1]
K00458 ALOX12; arachidonate 12-lipoxygenase [EC:1.13.11.31]
K00458 ALOX12; arachidonate 12-lipoxygenase [EC:1.13.11.31]
K08021 ALOX12B; arachidonate 12-lipoxygenase (R-type) [EC:1.13.11.-]
K08022 ALOX15B; arachidonate 15-lipoxygenase (second type) / 8-lipoxygenase (S-type) [EC:1.13.11.33 1.13.11.-]
K17709 CYP2B6; cytochrome P450, family 2, subfamily B, polypeptide 6 [EC:1.14.13.-]
K17718 CYP2C8; cytochrome P450, family 2, subfamily C, polypeptide 8 [EC:1.14.14.1]
K17719 CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9 [EC:1.14.13.48 1.14.13.49 1.14.13.80 1.14.13.-]
K08726 EPHX2; soluble epoxide hydrolase [EC:3.3.2.10]
K00460 ALOX15; arachidonate 15-lipoxygenase [EC:1.13.11.33]
     00591 Linoleic acid metabolism [PATH:ptr00591]
     00592 alpha-Linolenic acid metabolism [PATH:ptr00592]
     01040 Biosynthesis of unsaturated fatty acids [PATH:ptr01040]
     01004 Lipid biosynthesis proteins [BR:ptr01004]
 
   Nucleotide metabolism
 
   Amino acid metabolism
 
   Metabolism of other amino acids
 
   Glycan biosynthesis and metabolism
 
   Metabolism of cofactors and vitamins
 
   Metabolism of terpenoids and polyketides
 
   Biosynthesis of other secondary metabolites
 
   Xenobiotics biodegradation and metabolism
 
   Enzyme families
 
 Genetic Information Processing
 
 Environmental Information Processing
 
   Membrane transport
 
   Signal transduction
     02020 Two-component system
     02022 Two-component system
     04014 Ras signaling pathway [PATH:ptr04014]
     04015 Rap1 signaling pathway [PATH:ptr04015]
     04010 MAPK signaling pathway [PATH:ptr04010]
     04013 MAPK signaling pathway - fly
     04011 MAPK signaling pathway - yeast
     04012 ErbB signaling pathway [PATH:ptr04012]
     04310 Wnt signaling pathway [PATH:ptr04310]
     04330 Notch signaling pathway [PATH:ptr04330]
     04340 Hedgehog signaling pathway [PATH:ptr04340]
     04350 TGF-beta signaling pathway [PATH:ptr04350]
     04390 Hippo signaling pathway [PATH:ptr04390]
     04391 Hippo signaling pathway -fly
     04370 VEGF signaling pathway [PATH:ptr04370]
       461315 KDR; kinase insert domain receptor (a type III receptor tyrosine kinase)
       457406 SH2D2A; SH2 domain containing 2A
       458253 PLCG1; phospholipase C, gamma 1
       454268 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific)
       454832 PRKCA; protein kinase C, alpha
       456276 PRKCG; protein kinase C, gamma
       453993 PRKCB; protein kinase C, beta
       468943 SPHK2; sphingosine kinase 2
       738821 SPHK1; sphingosine kinase 1
       466302 HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog
       473387 KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
       742713 NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog
       460182 RAF1; v-raf-1 murine leukemia viral oncogene homolog 1
       450188 MAP2K1; mitogen-activated protein kinase kinase 1 
       456390 MAP2K2; mitogen-activated protein kinase kinase 2
       100611792 dual specificity mitogen-activated protein kinase kinase 2-like
       454037 MAPK3; mitogen-activated protein kinase 3
       458680 MAPK1; mitogen-activated protein kinase 1
       467664 PLA2G4E; phospholipase A2, group IVE
       469617 PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent)
       453706 cytosolic phospholipase A2 beta-like
       747584 PLA2G4B; phospholipase A2, group IVB (cytosolic)
       468935 PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent)
       100610135 PLA2G4D; phospholipase A2, group IVD (cytosolic)
       453356 PLA2G4F; phospholipase A2, group IVF
       739598 PLA2G4B; phospholipase A2, group IVB
       749457 PLA2G4B; phospholipase A2, group IVB
       739798 PLA2G4B; phospholipase A2, group IVB
       740368 PLA2G4B; phospholipase A2, group IVB
       748705 PLA2G4B; phospholipase A2, group IVB
       742406 PPP3CC; protein phosphatase 3, catalytic subunit, gamma isozyme
       461403 PPP3CA; protein phosphatase 3, catalytic subunit, alpha isozyme
       450898 PPP3CB; protein phosphatase 3, catalytic subunit, beta isozyme
       736325 PPP3R2; protein phosphatase 3, regulatory subunit B, beta 
       100613118 PPP3R1; protein phosphatase 3, regulatory subunit B, alpha
       469972 NFATC2; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       464422 PTK2; PTK2 protein tyrosine kinase 2
       749831 SHC2; SHC (Src homology 2 domain containing) transforming protein 2
       452303 PXN; paxillin
       745248 CDC42; cell division cycle 42
       456609 CDC42; cell division cycle 42 (GTP binding protein, 25kDa)
       450161 MAPK14; mitogen-activated protein kinase 14 
       462644 MAPK13; mitogen-activated protein kinase 13 
       747077 MAPK12; mitogen-activated protein kinase 12
       744091 MAPKAPK2; mitogen-activated protein kinase-activated protein kinase 2
       460400 MAPKAPK3; mitogen-activated protein kinase-activated protein kinase 3
       463488 HSPB1; heat shock 27kDa protein 1
       458229 SRC; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
       463649 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
       460858 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
       457922 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
       471079 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
       456565 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       461836 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       455085 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       455855 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       741907 RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
       742575 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
       747131 uncharacterized LOC747131
       456035 AKT2; v-akt murine thymoma viral oncogene homolog 2
       740898 AKT1; v-akt murine thymoma viral oncogene homolog 1
       100609583 AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) 
       463893 NOS3; nitric oxide synthase 3 (endothelial cell)
       456457 CASP9; caspase 9, apoptosis-related cysteine peptidase
       100615623 BAD; BCL2-associated agonist of cell death
K05098 KDR; kinase insert domain protein receptor [EC:2.7.10.1]
K08273 SH2D2A; SH2 domain protein 2A
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K04718 SPHK; sphingosine kinase [EC:2.7.1.91]
K04718 SPHK; sphingosine kinase [EC:2.7.1.91]
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K17332 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K05725 PTK2; focal adhesion kinase 1 [EC:2.7.10.2]
K17447 SHC2; SHC- transforming protein 2
K05760 PXN; paxillin
K04393 CDC42; cell division control protein 42
K04393 CDC42; cell division control protein 42
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04443 MAPKAPK2; mitogen-activated protein kinase-activated protein kinase 2 [EC:2.7.11.1]
K04444 MAPKAPK3; mitogen-activated protein kinase-activated protein kinase 3 [EC:2.7.11.1]
K04455 HSPB1; heat shock protein beta-1
K05704 SRC; tyrosine-protein kinase Src [EC:2.7.10.2]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K13242 NOS3; nitric-oxide synthase, endothelial [EC:1.14.13.39]
K04399 CASP9; caspase 9 [EC:3.4.22.62]
K02158 BAD; BCL2-antagonist of cell death
     04630 Jak-STAT signaling pathway [PATH:ptr04630]
     04064 NF-kappa B signaling pathway [PATH:ptr04064]
       743494 T-cell receptor alpha chain V region RL-5-like
       100615597 BV7-9; uncharacterized LOC100615597
       100613861 BV10-1; uncharacterized LOC100613861
       100608969 T-cell receptor beta chain T17T-22-like
       100608467 T-cell receptor beta chain T17T-22-like
       742771 T-cell receptor beta chain T17T-22-like
       456715 LCK; lymphocyte-specific protein tyrosine kinase
       459427 ZAP70; zeta-chain (TCR) associated protein kinase 70kDa
       743295 LAT; linker for activation of T cells
       458253 PLCG1; phospholipase C, gamma 1
       450288 PRKCQ; protein kinase C, theta
       745068 uncharacterized LOC745068
       464586 SYK; spleen tyrosine kinase
       472771 LYN; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog
       450641 BLNK; B-cell linker
       465759 BTK; Bruton agammaglobulinemia tyrosine kinase
       454268 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific)
       463235 CARD11; caspase recruitment domain family, member 11
       456984 BCL10; B-cell CLL/lymphoma 10
       468549 MALT1; mucosa associated lymphoid tissue lymphoma translocation gene 1
       450200 IL1B; interleukin 1, beta
       459460 IL1R1; interleukin 1 receptor, type I
       460269 MYD88; myeloid differentiation primary response gene (88)
       465935 IRAK1; interleukin-1 receptor-associated kinase 1
       466962 IRAK4; interleukin-1 receptor-associated kinase 4
       451702 TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase
       494186 TNF; tumor necrosis factor
       466934 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       462397 RIPK1; receptor (TNFRSF)-interacting serine-threonine kinase 1
       454154 TRADD; TNFRSF1A-associated via death domain
       464876 TRAF2; TNF receptor-associated factor 2
       457711 TRAF5; TNF receptor-associated factor 5
       451508 BIRC2; baculoviral IAP repeat containing 2
       451507 BIRC3; baculoviral IAP repeat containing 3
       465035 DDX58; DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
       455146 TRIM25; tripartite motif containing 25
       458239 LBP; lipopolysaccharide binding protein
       462118 CD14; CD14 molecule
       743242 TLR4; toll-like receptor 4
       746178 LY96; lymphocyte antigen 96
       451654 TIRAP; toll-interleukin 1 receptor (TIR) domain containing adaptor protein
       100500706 TICAM2; toll-like receptor adaptor molecule 2
       468677 TICAM1; toll-like receptor adaptor molecule 1
       473802 CD40LG; CD40 ligand
       100615583 CD40; CD40 molecule, TNF receptor superfamily member 5
       453178 TRAF3; TNF receptor-associated factor 3
       467353 TNFSF11; tumor necrosis factor (ligand) superfamily, member 11
       468560 TNFRSF11A; tumor necrosis factor receptor superfamily, member 11a, NFKB activator
       494185 LTA; lymphotoxin alpha (TNF superfamily, member 1)
       744486 LTB; lymphotoxin beta (TNF superfamily, member 3)
       468687 TNFSF14; tumor necrosis factor (ligand) superfamily, member 14
       451778 LTBR; lymphotoxin beta receptor (TNFR superfamily, member 3)
       454750 MAP3K14; mitogen-activated protein kinase kinase kinase 14
       462888 MAP3K7; mitogen-activated protein kinase kinase kinase 7
       458845 TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1
       463057 TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2
       473550 TAB3; TGF-beta activated kinase 1/MAP3K7 binding protein 3
       467323 TNFSF13B; tumor necrosis factor (ligand) superfamily, member 13b
       746611 TNFRSF13C; tumor necrosis factor receptor superfamily, member 13C
       100610002 NF-kappa-B essential modulator-like
       450673 CHUK; conserved helix-loop-helix ubiquitous kinase 
       472749 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
       736762 PIAS4; protein inhibitor of activated STAT, 4
       749975 UBE2I; ubiquitin-conjugating enzyme E2I
       451530 ATM; ataxia telangiectasia mutated
       450935 LRDD; leucine-rich repeats and death domain containing
       451740 ERC1; ELKS/RAB6-interacting/CAST family member 1
       467426 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       461406 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       466665 RELA; v-rel reticuloendotheliosis viral oncogene homolog A (avian)
       459872 CFLAR; CASP8 and FADD-like apoptosis regulator
       473765 XIAP; X-linked inhibitor of apoptosis
       458156 BCL2L1; BCL2-like 1
       738409 BCL2; B-cell CLL/lymphoma 2
       743748 TRAF1; TNF receptor-associated factor 1
       100610077 BCL2A1; BCL2-related protein A1
       450697 NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
       471205 IL8; interleukin 8
       472136 TNFAIP3; tumor necrosis factor, alpha-induced protein 3
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       454593 CCL4; chemokine (C-C motif) ligand 4
       455004 CCL4; chemokine (C-C motif) ligand 4
       457059 VCAM1; vascular cell adhesion molecule 1
       738078 PLAU; plasminogen activator, urokinase
       454131 CSNK2A2; casein kinase 2, alpha prime polypeptide
       458448 CSNK2A1; casein kinase 2, alpha 1 polypeptide
       744778 CSNK2B; casein kinase 2, beta polypeptide
       456119 RELB; v-rel reticuloendotheliosis viral oncogene homolog B
       748142 CCL13; chemokine (C-C motif) ligand 13
       473220 CCL19; chemokine (C-C motif) ligand 19
       746205 CCL21; chemokine (C-C motif) ligand 21
       741624 uncharacterized LOC741624
       450196 ICAM1; intercellular adhesion molecule 1
K10784 TRAV; T cell receptor alpha chain V region
K10785 TRBV; T-cell receptor beta chain V region
K10785 TRBV; T-cell receptor beta chain V region
K10785 TRBV; T-cell receptor beta chain V region
K10785 TRBV; T-cell receptor beta chain V region
K10785 TRBV; T-cell receptor beta chain V region
K05856 LCK; lymphocyte cell-specific protein tyrosine kinase [EC:2.7.10.2]
K07360 ZAP70; tyrosine-protein kinase ZAP-70 [EC:2.7.10.2]
K07362 LAT; linker for activation of T cells
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K18052 PRKCQ; novel protein kinase C theta type [EC:2.7.11.13]
K06856 IGH; immunoglobulin heavy chain
K05855 SYK; spleen tyrosine kinase [EC:2.7.10.2]
K05854 LYN; tyrosine-protein kinase Lyn [EC:2.7.10.2]
K07371 BLNK; B-cell linker protein
K07370 BTK; Bruton agammaglobulinemia tyrosine kinase [EC:2.7.10.2]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K07367 CARD11; caspase recruitment domain-containing protein 11
K07368 BCL10; B-cell CLL/lymphoma 10
K07369 MALT1; mucosa-associated lymphoid tissue lymphoma translocation protein 1 [EC:3.4.22.-]
K04519 IL1B; interleukin 1 beta
K04386 IL1R1; interleukin 1 receptor type I
K04729 MYD88; myeloid differentiation primary response protein MyD88
K04730 IRAK1; interleukin-1 receptor-associated kinase 1 [EC:2.7.11.1]
K04733 IRAK4; interleukin-1 receptor-associated kinase 4 [EC:2.7.11.1]
K03175 TRAF6; TNF receptor-associated factor 6
K03156 TNFA; tumor necrosis factor superfamily, member 2
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K03171 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
K03173 TRAF2; TNF receptor-associated factor 2
K09849 TRAF5; TNF receptor-associated factor 5
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K12646 DDX58; ATP-dependent RNA helicase DDX58 [EC:3.6.3.14]
K10652 TRIM25; tripartite motif-containing protein 25 [EC:6.3.2.19]
K05399 LBP; lipopolysaccharide-binding protein
K04391 CD14; CD14 antigen
K10160 TLR4; toll-like receptor 4
K05400 LY96; lymphocyte antigen 96
K05403 TIRAP; toll-interleukin 1 receptor (TIR) domain-containing adaptor protein
K05409 TIRP; TRIF-related adaptor molecule
K05842 TRIF; toll-like receptor adapter molecule 1
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K03174 TRAF3; TNF receptor-associated factor 3
K05473 TNFSF11; tumor necrosis factor ligand superfamily member 11
K05147 TNFRSF11A; tumor necrosis factor receptor superfamily member 11A
K05468 LTA; lymphotoxin alpha (TNF superfamily, member 1)
K03157 LTB; lymphotoxin beta (TNF superfamily, member 3)
K05477 TNFSF14; tumor necrosis factor ligand superfamily member 14
K03159 TNFRSF3; lymphotoxin beta receptor TNFR superfamily member 3
K04466 MAP3K14; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04403 MAP3K7IP1; TAK1-binding protein 1
K04404 MAP3K7IP2; TAK1-binding protein 2
K12793 MAP3K7IP3; TAK1-binding protein 3
K05476 TNFSF13B; tumor necrosis factor ligand superfamily member 13B
K05151 TNFRSF13C; tumor necrosis factor receptor superfamily member 13C
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K16065 PIAS4; E3 SUMO-protein ligase PIAS4 [EC:6.3.2.-]
K10577 UBE2I; ubiquitin-conjugating enzyme E2 I [EC:6.3.2.19]
K04728 ATM; ataxia telangiectasia mutated family protein [EC:2.7.11.1]
K10130 LRDD; leucine-rich repeats and death domain-containing protein
K16072 ERC1; ELKS/RAB6-interacting/CAST family member 1
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K04724 CFLAR; CASP8 and FADD-like apoptosis regulator
K04725 XIAP; E3 ubiquitin-protein ligase XIAP
K04570 BCL2L1; BCL2-like 1 (apoptosis regulator Bcl-X)
K02161 BCL2; apoptosis regulator BCL-2
K03172 TRAF1; TNF receptor-associated factor 1
K02162 BCL2A1; hematopoietic BCL2-related protein A1
K04469 NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
K10030 IL8; interleukin 8
K11859 TNFAIP3; tumor necrosis factor, alpha-induced protein 3 [EC:3.4.19.12 6.3.2.19]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K12964 CCL4; C-C motif chemokine 4
K12964 CCL4; C-C motif chemokine 4
K06527 VCAM1; vascular cell adhesion molecule 1
K01348 PLAU; urokinase plasminogen activator [EC:3.4.21.73]
K03097 CSNK2A; casein kinase II subunit alpha [EC:2.7.11.1]
K03097 CSNK2A; casein kinase II subunit alpha [EC:2.7.11.1]
K03115 CSNK2B; casein kinase II subunit beta
K09253 RELB; transcription factor RelB
K16595 CCL13; C-C motif chemokine 13
K05512 CCL19; C-C motif chemokine 19
K16062 CCL21; C-C motif chemokine 21
K10031 CXCL12; C-X-C motif chemokine 12
K06490 ICAM1; intercellular adhesion molecule 1
     04668 TNF signaling pathway [PATH:ptr04668]
       494186 TNF; tumor necrosis factor
       466934 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       464116 BAG4; BCL2-associated athanogene 4
       454154 TRADD; TNFRSF1A-associated via death domain
       464876 TRAF2; TNF receptor-associated factor 2
       457711 TRAF5; TNF receptor-associated factor 5
       462397 RIPK1; receptor (TNFRSF)-interacting serine-threonine kinase 1
       451508 BIRC2; baculoviral IAP repeat containing 2
       451507 BIRC3; baculoviral IAP repeat containing 3
       462888 MAP3K7; mitogen-activated protein kinase kinase kinase 7
       458845 TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1
       463057 TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2
       473550 TAB3; TGF-beta activated kinase 1/MAP3K7 binding protein 3
       455065 MAP2K4; mitogen-activated protein kinase kinase 4
       743199 MAP2K7; mitogen-activated protein kinase kinase 7
       450445 MAPK8; mitogen-activated protein kinase 8
       461358 MAPK10; mitogen-activated protein kinase 10
       462336 MAPK9; mitogen-activated protein kinase 9
       456893 JUN; jun proto-oncogene
       458191 ITCH; itchy E3 ubiquitin protein ligase
       459872 CFLAR; CASP8 and FADD-like apoptosis regulator
       746715 dual specificity mitogen-activated protein kinase kinase 3-like
       454515 MAP2K3; mitogen-activated protein kinase kinase 3
       468310 MAP2K6; mitogen-activated protein kinase kinase 6
       450161 MAPK14; mitogen-activated protein kinase 14 
       462644 MAPK13; mitogen-activated protein kinase 13 
       747077 MAPK12; mitogen-activated protein kinase 12
       469969 CEBPB; CCAAT/enhancer binding protein (C/EBP), beta
       463023 MAP3K5; mitogen-activated protein kinase kinase kinase 5
       454750 MAP3K14; mitogen-activated protein kinase kinase kinase 14
       100610002 NF-kappa-B essential modulator-like
       472749 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
       450673 CHUK; conserved helix-loop-helix ubiquitous kinase 
       467426 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       466665 RELA; v-rel reticuloendotheliosis viral oncogene homolog A (avian)
       461406 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       450384 MAP3K8; mitogen-activated protein kinase kinase kinase 8
       450188 MAP2K1; mitogen-activated protein kinase kinase 1 
       454037 MAPK3; mitogen-activated protein kinase 3
       458680 MAPK1; mitogen-activated protein kinase 1
       739162 RPS6KA5; ribosomal protein S6 kinase, 90kDa, polypeptide 5
       451715 RPS6KA4; ribosomal protein S6 kinase, 90kDa, polypeptide 4
       459901 CREB1; cAMP responsive element binding protein 1
       451704 CREB3L1; cAMP responsive element binding protein 3-like 1
       468672 CREB3L3; cAMP responsive element binding protein 3-like 3
       738928 CREB3L2; cAMP responsive element binding protein 3-like 2
       457341 CREB3L4; cAMP responsive element binding protein 3-like 4
       739083 ATF2; activating transcription factor 2
       101059354 ATF2; activating transcription factor 2
       744513 ATF4; activating transcription factor 4 (tax-responsive enhancer element B67)
       463318 CREB5; cAMP responsive element binding protein 5
       745411 ATF6B; activating transcription factor 6 beta
       452820 RIPK3; receptor-interacting serine-threonine kinase 3
       736069 MLKL; mixed lineage kinase domain-like
       452388 PGAM5; phosphoglycerate mutase family member 5
       465266 DNM1L; dynamin 1-like
       451389 FADD; Fas (TNFRSF6)-associated via death domain
       746477 CASP8; caspase 8, apoptosis-related cysteine peptidase
       459873 CASP10; caspase 10, apoptosis-related cysteine peptidase
       450745 CASP7; caspase 7, apoptosis-related cysteine peptidase
       461669 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       748205 CCL2; chemokine (C-C motif) ligand 2
       747004 CCL5; chemokine (C-C motif) ligand 5
       459991 CCL20; chemokine (C-C motif) ligand 20
       461255 CXCL3; chemokine (C-X-C motif) ligand 3
       740176 CXCL2; chemokine (C-X-C motif) ligand 2
       740567 CXCL1; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
       461242 CXCL10; chemokine (C-X-C motif) ligand 10
       454115 CX3CL1; chemokine (C-X3-C motif) ligand 1
       457127 CSF1; colony stimulating factor 1 (macrophage)
       471627 CSF2; colony stimulating factor 2 (granulocyte-macrophage)
       738331 FAS; Fas (TNF receptor superfamily, member 6)
       459463 IL18R1; interleukin 18 receptor 1
       450200 IL1B; interleukin 1, beta
       463288 IL6; interleukin 6 (interferon, beta 2)
       737808 IL15; interleukin 15
       736309 LIF; leukemia inhibitory factor
       494185 LTA; lymphotoxin alpha (TNF superfamily, member 1)
       744209 BCL3; B-cell CLL/lymphoma 3
       454921 SOCS3; suppressor of cytokine signaling 3
       472136 TNFAIP3; tumor necrosis factor, alpha-induced protein 3
       743748 TRAF1; TNF receptor-associated factor 1
       453047 FOS; FBJ murine osteosarcoma viral oncogene homolog
       468739 JUNB; jun B proto-oncogene
       451511 MMP3; matrix metallopeptidase 3 (stromelysin 1, progelatinase)
       458294 MMP9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
       742887 MMP14; matrix metallopeptidase 14 (membrane-inserted)
       462437 EDN1; endothelin 1
       454083 NOD2; nucleotide-binding oligomerization domain containing 2
       450196 ICAM1; intercellular adhesion molecule 1
       736063 SELE; selectin E
       457059 VCAM1; vascular cell adhesion molecule 1
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       457968 TNFRSF1B; tumor necrosis factor receptor superfamily, member 1B
       453178 TRAF3; TNF receptor-associated factor 3
       463649 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
       460858 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
       457922 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
       471079 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
       456565 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       461836 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       455085 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       455855 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       456035 AKT2; v-akt murine thymoma viral oncogene homolog 2
       740898 AKT1; v-akt murine thymoma viral oncogene homolog 1
       100609583 AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) 
       463498 MAGI2; membrane associated guanylate kinase, WW and PDZ domain containing 2
K03156 TNFA; tumor necrosis factor superfamily, member 2
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K09558 BAG4; BCL2-associated athanogene 4
K03171 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
K03173 TRAF2; TNF receptor-associated factor 2
K09849 TRAF5; TNF receptor-associated factor 5
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04403 MAP3K7IP1; TAK1-binding protein 1
K04404 MAP3K7IP2; TAK1-binding protein 2
K12793 MAP3K7IP3; TAK1-binding protein 3
K04430 MAP2K4; mitogen-activated protein kinase kinase 4 [EC:2.7.12.2]
K04431 MAP2K7; mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04448 JUN; transcription factor AP-1
K05632 AIP4; atrophin-1 interacting protein 4 [EC:6.3.2.19]
K04724 CFLAR; CASP8 and FADD-like apoptosis regulator
K04432 MAP2K3; mitogen-activated protein kinase kinase 3 [EC:2.7.12.2]
K04432 MAP2K3; mitogen-activated protein kinase kinase 3 [EC:2.7.12.2]
K04433 MAP2K6; mitogen-activated protein kinase kinase 6 [EC:2.7.12.2]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K10048 CEBPB; CCAAT/enhancer binding protein (C/EBP), beta
K04426 MAP3K5; mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
K04466 MAP3K14; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K04735 RELA; transcription factor p65
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04415 MAP3K8; mitogen-activated protein kinase kinase kinase 8 [EC:2.7.11.25]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04445 MSK1; ribosomal protein S6 kinase alpha-5 [EC:2.7.11.1]
K16510 MSK2; ribosomal protein S6 kinase alpha-4 [EC:2.7.11.1]
K05870 CREB1; cyclic AMP-responsive element-binding protein 1
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K04450 ATF2; cyclic AMP-dependent transcription factor ATF-2
K04450 ATF2; cyclic AMP-dependent transcription factor ATF-2
K04374 ATF4; cyclic AMP-dependent transcription factor ATF-4
K09047 CREB5; cyclic AMP-responsive element-binding protein 5
K09049 ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta
K08847 RIPK3; receptor-interacting serine/threonine-protein kinase 3 [EC:2.7.11.1]
K08849 MLKL; mixed lineage kinase domain-like [EC:2.7.11.1]
K15637 PGAM5; serine/threonine-protein phosphatase PGAM5 [EC:3.1.3.16]
K17065 DNM1L; dynamin 1-like protein [EC:3.6.5.5]
K02373 FADD; FAS-associated death domain protein
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K04400 CASP10; caspase 10 [EC:3.4.22.63]
K04397 CASP7; caspase 7 [EC:3.4.22.60]
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K14624 CCL2; C-C motif chemokine 2
K12499 CCL5; C-C motif chemokine 5
K14625 CCL20; C-C motif chemokine 20
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K12671 CXCL10; C-X-C motif chemokine 10
K05508 CX3CL1; C-X3-C motif chemokine 1
K05453 CSF1; macrophage colony-stimulating factor 1
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K05173 IL18R1; interleukin 18 receptor 1
K04519 IL1B; interleukin 1 beta
K05405 IL6; interleukin 6
K05433 IL15; interleukin 15
K05419 LIF; leukemia inhibitory factor
K05468 LTA; lymphotoxin alpha (TNF superfamily, member 1)
K09258 BCL3; B-cell CLL/lymphoma protein 3
K04696 SOCS3; suppressor of cytokine signaling 3
K11859 TNFAIP3; tumor necrosis factor, alpha-induced protein 3 [EC:3.4.19.12 6.3.2.19]
K03172 TRAF1; TNF receptor-associated factor 1
K04379 FOS; proto-oncogene protein c-fos
K09028 JUNB; transcription factor jun-B
K01394 MMP3; matrix metalloproteinase-3 (stromelysin 1, progelatinase) [EC:3.4.24.17]
K01403 MMP9; matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
K07763 MMP14; matrix metalloproteinase-14 (membrane-inserted) [EC:3.4.24.80]
K16366 EDN1; endothelin-1
K10165 NOD2; nucleotide-binding oligomerization domain-containing protein 2
K06490 ICAM1; intercellular adhesion molecule 1
K06494 SELE; selectin, endothelial cell
K06527 VCAM1; vascular cell adhesion molecule 1
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K05141 TNFRSF1B; tumor necrosis factor receptor superfamily member 1B
K03174 TRAF3; TNF receptor-associated factor 3
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K05629 AIP1; atrophin-1 interacting protein 1
     04066 HIF-1 signaling pathway [PATH:ptr04066]
     04068 FoxO signaling pathway [PATH:ptr04068]
     04020 Calcium signaling pathway [PATH:ptr04020]
     04070 Phosphatidylinositol signaling system [PATH:ptr04070]
     04024 cAMP signaling pathway [PATH:ptr04024]
     04022 cGMP - PKG signaling pathway [PATH:ptr04022]
     04151 PI3K-Akt signaling pathway [PATH:ptr04151]
     04152 AMPK signaling pathway [PATH:ptr04152]
     04150 mTOR signaling pathway [PATH:ptr04150]
     04075 Plant hormone signal transduction
 
   Signaling molecules and interaction
 
 Cellular Processes
 
 Organismal Systems
 
   Immune system
 
   Endocrine system
     04911 Insulin secretion [PATH:ptr04911]
     04910 Insulin signaling pathway [PATH:ptr04910]
     04920 Adipocytokine signaling pathway [PATH:ptr04920]
     03320 PPAR signaling pathway [PATH:ptr03320]
     04912 GnRH signaling pathway [PATH:ptr04912]
     04913 Ovarian Steroidogenesis [PATH:ptr04913]
       462868 CGA; glycoprotein hormones, alpha polypeptide
       468950 LHB; luteinizing hormone beta polypeptide
       100615277 LHCGR; luteinizing hormone/choriogonadotropin receptor
       469986 GNAS; GNAS complex locus
       463392 ADCY1; adenylate cyclase 1 (brain)
       461715 ADCY2; adenylate cyclase 2
       459070 ADCY3; adenylate cyclase 3
       452819 ADCY4; adenylate cyclase 4
       470905 ADCY5; adenylate cyclase 5
       451866 ADCY6; adenylate cyclase 6
       473278 ADCY7; adenylate cyclase 7
       464400 ADCY8; adenylate cyclase 8 (brain)
       100615296 adenylate cyclase type 8-like
       453869 ADCY9; adenylate cyclase 9
       469367 PRKACB; protein kinase, cAMP-dependent, catalytic, beta
       472944 PRKACG; protein kinase, cAMP-dependent, catalytic, gamma
       449495 PRKX; protein kinase, X-linked 
       455776 PRKACA; protein kinase, cAMP-dependent, catalytic, alpha
       751063 cAMP-dependent protein kinase catalytic subunit PRKX-like
       467664 PLA2G4E; phospholipase A2, group IVE
       469617 PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent)
       453706 cytosolic phospholipase A2 beta-like
       747584 PLA2G4B; phospholipase A2, group IVB (cytosolic)
       468935 PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent)
       100610135 PLA2G4D; phospholipase A2, group IVD (cytosolic)
       453356 PLA2G4F; phospholipase A2, group IVF
       739598 PLA2G4B; phospholipase A2, group IVB
       749457 PLA2G4B; phospholipase A2, group IVB
       739798 PLA2G4B; phospholipase A2, group IVB
       740368 PLA2G4B; phospholipase A2, group IVB
       748705 PLA2G4B; phospholipase A2, group IVB
       450428 ALOX5; arachidonate 5-lipoxygenase
       456896 cytochrome P450 2J2-like
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       449570 INS; insulin
       455649 INSR; insulin receptor
       741055 IGF1; insulin-like growth factor 1 (somatomedin C)
       453676 IGF1R; insulin-like growth factor 1 receptor
       455722 LDLR; low density lipoprotein receptor
       452359 SCARB1; scavenger receptor class B, member 1
       746738 STAR; steroidogenic acute regulatory protein
       748998 CYP11A1; cytochrome P450, family 11, subfamily A, polypeptide 1 
       450141 CYP17A1; cytochrome P450, family 17, subfamily A, polypeptide 1 
       454689 HSD17B1; hydroxysteroid (17-beta) dehydrogenase 1
       100614183 estradiol 17-beta-dehydrogenase 1-like
       454269 HSD17B2; hydroxysteroid (17-beta) dehydrogenase 2
       100612718 AKR1C3; aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)
       747814 HSD17B7; hydroxysteroid (17-beta) dehydrogenase 7
       466046 3-keto-steroid reductase-like
       469446 HSD3B1; hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
       457165 HSD3B2; hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
       736618 FSHB; follicle stimulating hormone, beta polypeptide
       470371 FSHR; follicle stimulating hormone receptor
       453433 CYP19A1; cytochrome P450, family 19, subfamily A, polypeptide 1
       459163 CYP1B1; cytochrome P450 1B1
       453744 cytochrome P450 1A1-like
       471630 GDF9; growth differentiation factor 9
       473873 BMP15; bone morphogenetic protein 15
       471851 BMP6; bone morphogenetic protein 6
K08522 CGA; glycoprotein hormones, alpha polypeptide
K08521 LHB; luteinizing hormone beta polypeptide
K04248 LHCGR; luteinizing hormone/choriogonadotropin receptor
K04632 GNAS; guanine nucleotide-binding protein G(s) subunit alpha
K08041 ADCY1; adenylate cyclase 1 [EC:4.6.1.1]
K08042 ADCY2; adenylate cyclase 2 [EC:4.6.1.1]
K08043 ADCY3; adenylate cyclase 3 [EC:4.6.1.1]
K08044 ADCY4; adenylate cyclase 4 [EC:4.6.1.1]
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K08046 ADCY6; adenylate cyclase 6 [EC:4.6.1.1]
K08047 ADCY7; adenylate cyclase 7 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08049 ADCY9; adenylate cyclase 9 [EC:4.6.1.1]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K00461 ALOX5; arachidonate 5-lipoxygenase [EC:1.13.11.34]
K07418 CYP2J; cytochrome P450, family 2, subfamily J [EC:1.14.14.1]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K04526 INS; insulin
K04527 INSR; insulin receptor [EC:2.7.10.1]
K05459 IGF1; insulin-like growth factor 1
K05087 IGF1R; insulin-like growth factor 1 receptor [EC:2.7.10.1]
K12473 LDLR; low-density lipoprotein receptor
K13885 SCARB1; scavenger receptor class B, member 1
K16931 STAR; steroidogenic acute regulatory protein, mitochondrial
K00498 CYP11A; cholesterol monooxygenase (side-chain-cleaving) [EC:1.14.15.6]
K00512 CYP17A; steroid 17alpha-monooxygenase / 17alpha-hydroxyprogesterone aldolase [EC:1.14.99.9 4.1.2.30]
K00044 HSD17B1; 17beta-estradiol 17-dehydrogenase [EC:1.1.1.62]
K00044 HSD17B1; 17beta-estradiol 17-dehydrogenase [EC:1.1.1.62]
K13368 HSD17B2; 17beta-estradiol 17-dehydrogenase / 3alpha(17beta)-hydroxysteroid dehydrogenase (NAD+) [EC:1.1.1.62 1.1.1.239]
K04119 AKR1C3; aldo-keto reductase family 1 member C3 [EC:1.1.1.64 1.1.1.188 1.1.1.213]
K13373 HSD17B7; 17beta-estradiol 17-dehydrogenase / 3beta-hydroxysteroid 3-dehydrogenase [EC:1.1.1.62 1.1.1.270]
K13373 HSD17B7; 17beta-estradiol 17-dehydrogenase / 3beta-hydroxysteroid 3-dehydrogenase [EC:1.1.1.62 1.1.1.270]
K00070 HSD3B; 3beta-hydroxy-delta5-steroid dehydrogenase / steroid delta-isomerase [EC:1.1.1.145 5.3.3.1]
K00070 HSD3B; 3beta-hydroxy-delta5-steroid dehydrogenase / steroid delta-isomerase [EC:1.1.1.145 5.3.3.1]
K05250 FSH; follicle stimulating hormone
K04247 FSHR; follicle stimulating hormone receptor
K07434 CYP19A; aromatase [EC:1.14.14.14]
K07410 CYP1B1; cytochrome P450, family 1, subfamily B, polypeptide 1 [EC:1.14.14.1]
K07408 CYP1A1; cytochrome P450, family 1, subfamily A, polypeptide 1 [EC:1.14.14.1]
K05498 GDF9_9B; growth differentiation factor 9/9B
K05498 GDF9_9B; growth differentiation factor 9/9B
K16620 BMP6; bone morphogenetic protein 6
     04915 Estrogen signaling pathway [PATH:ptr04915]
     04914 Progesterone-mediated oocyte maturation [PATH:ptr04914]
     04917 Prolactin signaling pathway [PATH:ptr04917]
     04921 Oxytocin signaling pathway [PATH:ptr04921]
       746851 OXT; oxytocin/neurophysin I prepropeptide
       738742 OXTR; oxytocin receptor
       472962 GNAQ; guanine nucleotide binding protein (G protein), q polypeptide
       466302 HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog
       473387 KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
       742713 NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog
       460182 RAF1; v-raf-1 murine leukemia viral oncogene homolog 1
       450188 MAP2K1; mitogen-activated protein kinase kinase 1 
       456390 MAP2K2; mitogen-activated protein kinase kinase 2
       100611792 dual specificity mitogen-activated protein kinase kinase 2-like
       454037 MAPK3; mitogen-activated protein kinase 3
       458680 MAPK1; mitogen-activated protein kinase 1
       467664 PLA2G4E; phospholipase A2, group IVE
       469617 PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent)
       453706 cytosolic phospholipase A2 beta-like
       747584 PLA2G4B; phospholipase A2, group IVB (cytosolic)
       468935 PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent)
       100610135 PLA2G4D; phospholipase A2, group IVD (cytosolic)
       453356 PLA2G4F; phospholipase A2, group IVF
       739598 PLA2G4B; phospholipase A2, group IVB
       749457 PLA2G4B; phospholipase A2, group IVB
       739798 PLA2G4B; phospholipase A2, group IVB
       740368 PLA2G4B; phospholipase A2, group IVB
       748705 PLA2G4B; phospholipase A2, group IVB
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       453532 MAP2K5; mitogen-activated protein kinase kinase 5
       454499 MAPK7; mitogen-activated protein kinase 7
       456893 JUN; jun proto-oncogene
       453047 FOS; FBJ murine osteosarcoma viral oncogene homolog
       461760 MEF2C; myocyte enhancer factor 2C
       747688 CCND1; cyclin D1
       473591 ELK1; ELK1, member of ETS oncogene family
       100612063 RYR1; ryanodine receptor 1 (skeletal)
       457846 RYR2; ryanodine receptor 2 (cardiac)
       453296 RYR3; ryanodine receptor 3
       745433 CD38; CD38 molecule
       470101 TRPM2; transient receptor potential cation channel, subfamily M, member 2
       468312 KCNJ2; potassium inwardly-rectifying channel, subfamily J, member 2
       746628 KCNJ12; potassium inwardly-rectifying channel, subfamily J, member 12
       468378 KCNJ12; potassium inwardly-rectifying channel, subfamily J, member 12
       470209 KCNJ4; potassium inwardly-rectifying channel, subfamily J, member 4
       468940 KCNJ14; potassium inwardly-rectifying channel, subfamily J, member 14
       453330 PLCB2; phospholipase C, beta 2
       458093 PLCB4; phospholipase C, beta 4
       469875 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific)
       451290 PLCB3; phospholipase C, beta 3 (phosphatidylinositol-specific)
       454832 PRKCA; protein kinase C, alpha
       456276 PRKCG; protein kinase C, gamma
       453993 PRKCB; protein kinase C, beta
       454350 EEF2K; eukaryotic elongation factor-2 kinase
       100614367 elongation factor 2-like
       466914 CACNA1C; calcium channel, voltage-dependent, L type, alpha 1C subunit
       460447 CACNA1D; calcium channel, voltage-dependent, L type, alpha 1D subunit
       465629 CACNA1F; calcium channel, voltage-dependent, L type, alpha 1F subunit
       740711 voltage-dependent L-type calcium channel subunit alpha-1F-like
       469635 CACNA1S; calcium channel, voltage-dependent, L type, alpha 1S subunit
       454624 CACNB1; calcium channel, voltage-dependent, beta 1 subunit
       740138 CACNB2; calcium channel, voltage-dependent, beta 2 subunit
       451867 CACNB3; calcium channel, voltage-dependent, beta 3 subunit
       459660 CACNB4; calcium channel, voltage-dependent, beta 4 subunit
       463504 CACNA2D1; calcium channel, voltage-dependent, alpha 2/delta subunit 1
       460396 CACNA2D2; calcium channel, voltage-dependent, alpha 2/delta subunit 2
       460457 CACNA2D3; calcium channel, voltage-dependent, alpha 2/delta subunit 3
       466912 CACNA2D4; calcium channel, voltage-dependent, alpha 2/delta subunit 4
       741106 CACNG1; calcium channel, voltage-dependent, gamma subunit 1
       458799 CACNG2; calcium channel, voltage-dependent, gamma subunit 2
       746707 CACNG3; calcium channel, voltage-dependent, gamma subunit 3
       741406 CACNG4; calcium channel, voltage-dependent, gamma subunit 4
       100609964 CACNG5; calcium channel, voltage-dependent, gamma subunit 5
       749208 CACNG6; calcium channel, voltage-dependent, gamma subunit 6
       749196 CACNG7; calcium channel, voltage-dependent, gamma subunit 7
       101058889 CACNG8; calcium channel, voltage-dependent, gamma subunit 8
       460134 ITPR1; inositol 1,4,5-trisphosphate receptor, type 1
       473389 ITPR2; inositol 1,4,5-trisphosphate receptor, type 2
       462618 ITPR3; inositol 1,4,5-trisphosphate receptor, type 3
       737566 CALML5; calmodulin-like 5
       466008 CALML3; calmodulin-like 3
       459213 CALM2; calmodulin 2 (phosphorylase kinase, delta)
       738819 CALM1; calmodulin 1 (phosphorylase kinase, delta) 
       456153 CALM3; calmodulin 3 (phosphorylase kinase, delta)
       743250 CALML6; calmodulin-like 6
       742406 PPP3CC; protein phosphatase 3, catalytic subunit, gamma isozyme
       461403 PPP3CA; protein phosphatase 3, catalytic subunit, alpha isozyme
       450898 PPP3CB; protein phosphatase 3, catalytic subunit, beta isozyme
       736325 PPP3R2; protein phosphatase 3, regulatory subunit B, beta 
       100613118 PPP3R1; protein phosphatase 3, regulatory subunit B, alpha
       455485 NFATC1; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
       469972 NFATC2; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
       454184 NFATC3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
       452821 NFATC4; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
       469623 RGS2; regulator of G-protein signaling 2, 24kDa
       458525 RCAN1; regulator of calcineurin 1
       454438 CAMKK1; calcium/calmodulin-dependent protein kinase kinase 1, alpha
       452320 CAMKK2; calcium/calmodulin-dependent protein kinase kinase 2, beta
       741802 PRKAA2; protein kinase, AMP-activated, alpha 2 catalytic subunit
       471564 PRKAA1; protein kinase, AMP-activated, alpha 1 catalytic subunit
       452297 PRKAB1; protein kinase, AMP-activated, beta 1 non-catalytic subunit
       457245 PRKAB2; protein kinase, AMP-activated, beta 2 non-catalytic subunit
       470648 PRKAG3; protein kinase, AMP-activated, gamma 3 non-catalytic subunit
       451872 PRKAG1; protein kinase, AMP-activated, gamma 1 non-catalytic subunit
       463879 PRKAG2; protein kinase, AMP-activated, gamma 2 non-catalytic subunit
       460153 CAMK1; calcium/calmodulin-dependent protein kinase I
       469667 CAMK1G; calcium/calmodulin-dependent protein kinase IG
       450308 CAMK1D; calcium/calmodulin-dependent protein kinase ID
       450529 calcium/calmodulin-dependent protein kinase type II subunit gamma-like
       461445 CAMK2D; calcium/calmodulin-dependent protein kinase II delta
       462189 CAMK2A; calcium/calmodulin-dependent protein kinase II alpha
       738330 CAMK2G; calcium/calmodulin-dependent protein kinase II gamma
       461992 CAMK4; calcium/calmodulin-dependent protein kinase IV
       463893 NOS3; nitric oxide synthase 3 (endothelial cell)
       466769 GUCY1A2; guanylate cyclase 1, soluble, alpha 2
       100608597 GUCY1A3; guanylate cyclase 1, soluble, alpha 3
       452727 GUCY1B2; guanylate cyclase soluble subunit beta-2-like
       461565 GUCY1B3; guanylate cyclase 1, soluble, beta 3
       457329 NPR1; natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A)
       465084 NPR2; natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B)
       460640 MYLK; myosin light chain kinase
       742591 MYLK2; myosin light chain kinase 2
       465143 MYLK3; myosin light chain kinase 3
       471840 MYLK4; myosin light chain kinase family, member 4
       101057233 MYLK; myosin light chain kinase
       747356 MYL6B; myosin, light chain 6B, alkali, smooth muscle and non-muscle
       458216 MYL9; myosin, light chain 9, regulatory
       450133 ACTB; actin, beta
       744996 actin
       746570 ACTG1; actin, gamma 1
       461014 RHOA; ras homolog family member A
       455326 ROCK1; Rho-associated, coiled-coil containing protein kinase 1
       470307 ROCK2; Rho-associated, coiled-coil containing protein kinase 2
       462795 PPP1CC; protein phosphatase 1, catalytic subunit, gamma isoform
       745709 PPP1CA; protein phosphatase 1, catalytic subunit, alpha isozyme
       743656 PPP1CC; protein phosphatase 1, catalytic subunit, gamma isoform
       459118 PPP1CB; protein phosphatase 1, catalytic subunit, beta isozyme
       452095 PPP1R12A; protein phosphatase 1, regulatory subunit 12A
       457629 PPP1R12B; protein phosphatase 1, regulatory subunit 12B
       456295 PPP1R12C; protein phosphatase 1, regulatory subunit 12C
       469986 GNAS; GNAS complex locus
       463392 ADCY1; adenylate cyclase 1 (brain)
       461715 ADCY2; adenylate cyclase 2
       459070 ADCY3; adenylate cyclase 3
       452819 ADCY4; adenylate cyclase 4
       470905 ADCY5; adenylate cyclase 5
       451866 ADCY6; adenylate cyclase 6
       473278 ADCY7; adenylate cyclase 7
       464400 ADCY8; adenylate cyclase 8 (brain)
       100615296 adenylate cyclase type 8-like
       453869 ADCY9; adenylate cyclase 9
       469367 PRKACB; protein kinase, cAMP-dependent, catalytic, beta
       472944 PRKACG; protein kinase, cAMP-dependent, catalytic, gamma
       449495 PRKX; protein kinase, X-linked 
       455776 PRKACA; protein kinase, cAMP-dependent, catalytic, alpha
       751063 cAMP-dependent protein kinase catalytic subunit PRKX-like
       457093 GNAI3; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
       472425 GNAI1; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
       744773 GNAI2; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
       450173 GNAO1; guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
       463649 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
       460858 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
       457922 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
       471079 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
       456565 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       461836 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       455085 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       455855 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       458229 SRC; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
       737029 KCNJ3; potassium inwardly-rectifying channel, subfamily J, member 3
       474111 KCNJ6; potassium inwardly-rectifying channel, subfamily J, member 6
       469548 KCNJ9; potassium inwardly-rectifying channel, subfamily J, member 9
       451660 KCNJ5; potassium inwardly-rectifying channel, subfamily J, member 5
       463415 EGFR; epidermal growth factor receptor
       747442 CDKN1A; cyclin-dependent kinase inhibitor 1A (p21, Cip1)
K05243 OXT; oxytocin-neurophysin 1
K04229 OXTR; oxytocin receptor
K04634 GNAQ; guanine nucleotide-binding protein G(q) subunit alpha
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K04463 MAP2K5; mitogen-activated protein kinase kinase 5 [EC:2.7.12.2]
K04464 MAPK7; mitogen-activated protein kinase 7 [EC:2.7.11.24]
K04448 JUN; transcription factor AP-1
K04379 FOS; proto-oncogene protein c-fos
K04454 MEF2C; MADS-box transcription enhancer factor 2C
K04503 CCND1; cyclin D1
K04375 ELK1; ETS domain-containing protein Elk-1
K04961 RYR1; ryanodine receptor 1
K04962 RYR2; ryanodine receptor 2
K04963 RYR3; ryanodine receptor 3
K01242 CD38; ADP-ribosyl cyclase 1 [EC:3.2.2.6 2.4.99.20]
K04977 TRPM2; transient receptor potential cation channel subfamily M member 2
K04996 KCNJ2; potassium inwardly-rectifying channel subfamily J member 2
K05005 KCNJ12; potassium inwardly-rectifying channel subfamily J member 12
K05005 KCNJ12; potassium inwardly-rectifying channel subfamily J member 12
K04998 KCNJ4; potassium inwardly-rectifying channel subfamily J member 4
K05007 KCNJ14; potassium inwardly-rectifying channel subfamily J member 14
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K08292 EEF2K; elongation factor 2 kinase [EC:2.7.11.20]
K03234 EEF2; elongation factor 2
K04850 CACNA1C; voltage-dependent calcium channel L type alpha-1C
K04851 CACNA1D; voltage-dependent calcium channel L type alpha-1D
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04857 CACNA1S; voltage-dependent calcium channel L type alpha-1S
K04862 CACNB1; voltage-dependent calcium channel beta-1
K04863 CACNB2; voltage-dependent calcium channel beta-2
K04864 CACNB3; voltage-dependent calcium channel beta-3
K04865 CACNB4; voltage-dependent calcium channel beta-4
K04858 CACNA2D1; voltage-dependent calcium channel alpha-2/delta-1
K04859 CACNA2D2; voltage-dependent calcium channel alpha-2/delta-2
K04860 CACNA2D3; voltage-dependent calcium channel alpha-2/delta-3
K04861 CACNA2D4; voltage-dependent calcium channel alpha-2/delta-4
K04866 CACNG1; voltage-dependent calcium channel gamma-1
K04867 CACNG2; voltage-dependent calcium channel gamma-2
K04868 CACNG3; voltage-dependent calcium channel gamma-3
K04869 CACNG4; voltage-dependent calcium channel gamma-4
K04870 CACNG5; voltage-dependent calcium channel gamma-5
K04871 CACNG6; voltage-dependent calcium channel gamma-6
K04872 CACNG7; voltage-dependent calcium channel gamma-7
K04873 CACNG8; voltage-dependent calcium channel gamma-8
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K04446 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1
K17332 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2
K17333 NFATC3; nuclear factor of activated T-cells, cytoplasmic 3
K17334 NFATC4; nuclear factor of activated T-cells, cytoplasmic 4
K18154 RGS2; regulator of G-protein signaling 2
K17901 RCAN1; calcipressin-1
K07359 CAMKK; calcium/calmodulin-dependent protein kinase kinase [EC:2.7.11.17]
K07359 CAMKK; calcium/calmodulin-dependent protein kinase kinase [EC:2.7.11.17]
K07198 PRKAA; 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11]
K07198 PRKAA; 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11]
K07199 PRKAB; 5'-AMP-activated protein kinase, regulatory beta subunit
K07199 PRKAB; 5'-AMP-activated protein kinase, regulatory beta subunit
K07200 PRKAG; 5'-AMP-activated protein kinase, regulatory gamma subunit
K07200 PRKAG; 5'-AMP-activated protein kinase, regulatory gamma subunit
K07200 PRKAG; 5'-AMP-activated protein kinase, regulatory gamma subunit
K08794 CAMK1; calcium/calmodulin-dependent protein kinase I [EC:2.7.11.17]
K08794 CAMK1; calcium/calmodulin-dependent protein kinase I [EC:2.7.11.17]
K08794 CAMK1; calcium/calmodulin-dependent protein kinase I [EC:2.7.11.17]
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K05869 CAMK4; calcium/calmodulin-dependent protein kinase IV [EC:2.7.11.17]
K13242 NOS3; nitric-oxide synthase, endothelial [EC:1.14.13.39]
K12318 GUCY1A; guanylate cyclase soluble subunit alpha [EC:4.6.1.2]
K12318 GUCY1A; guanylate cyclase soluble subunit alpha [EC:4.6.1.2]
K12319 GUCY1B; guanylate cyclase soluble subunit beta [EC:4.6.1.2]
K12319 GUCY1B; guanylate cyclase soluble subunit beta [EC:4.6.1.2]
K12323 ANPRA; atrial natriuretic peptide receptor A [EC:4.6.1.2]
K12324 ANPRB; atrial natriuretic peptide receptor B [EC:4.6.1.2]
K00907 MYLK; myosin-light-chain kinase [EC:2.7.11.18]
K00907 MYLK; myosin-light-chain kinase [EC:2.7.11.18]
K00907 MYLK; myosin-light-chain kinase [EC:2.7.11.18]
K00907 MYLK; myosin-light-chain kinase [EC:2.7.11.18]
K00907 MYLK; myosin-light-chain kinase [EC:2.7.11.18]
K12751 MYL6; myosin light chain 6
K12755 MYL9; myosin regulatory light chain 9
K05692 ACTB_G1; actin beta/gamma 1
K05692 ACTB_G1; actin beta/gamma 1
K05692 ACTB_G1; actin beta/gamma 1
K04513 RHOA; Ras homolog gene family, member A
K04514 ROCK1; Rho-associated protein kinase 1 [EC:2.7.11.1]
K17388 ROCK2; Rho-associated protein kinase 2 [EC:2.7.11.1]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06270 PPP1R12A; protein phosphatase 1 regulatory subunit 12A
K12329 PPP1R12B; protein phosphatase 1 regulatory subunit 12B
K17457 PPP1R12C; protein phosphatase 1 regulatory subunit 12C
K04632 GNAS; guanine nucleotide-binding protein G(s) subunit alpha
K08041 ADCY1; adenylate cyclase 1 [EC:4.6.1.1]
K08042 ADCY2; adenylate cyclase 2 [EC:4.6.1.1]
K08043 ADCY3; adenylate cyclase 3 [EC:4.6.1.1]
K08044 ADCY4; adenylate cyclase 4 [EC:4.6.1.1]
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K08046 ADCY6; adenylate cyclase 6 [EC:4.6.1.1]
K08047 ADCY7; adenylate cyclase 7 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08049 ADCY9; adenylate cyclase 9 [EC:4.6.1.1]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04534 GNAO; guanine nucleotide-binding protein G(o) subunit alpha
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K05704 SRC; tyrosine-protein kinase Src [EC:2.7.10.2]
K04997 KCNJ3; potassium inwardly-rectifying channel subfamily J member 3
K05000 KCNJ6; potassium inwardly-rectifying channel subfamily J member 6
K05002 KCNJ9; potassium inwardly-rectifying channel subfamily J member 9
K04999 KCNJ5; potassium inwardly-rectifying channel subfamily J member 5
K04361 EGFR; epidermal growth factor receptor [EC:2.7.10.1]
K06625 CDKN1A; cyclin-dependent kinase inhibitor 1A
     04918 Thyroid hormone synthesis [PATH:ptr04918]
     04919 Thyroid hormone signaling pathway [PATH:ptr04919]
     04916 Melanogenesis [PATH:ptr04916]
     04614 Renin-angiotensin system [PATH:ptr04614]
 
   Circulatory system
 
   Digestive system
 
   Excretory system
 
   Nervous system
     04724 Glutamatergic synapse [PATH:ptr04724]
     04727 GABAergic synapse [PATH:ptr04727]
     04725 Cholinergic synapse [PATH:ptr04725]
     04728 Dopaminergic synapse [PATH:ptr04728]
     04726 Serotonergic synapse [PATH:ptr04726]
       467070 TPH2; tryptophan hydroxylase 2
       466453 TPH1; tryptophan hydroxylase 1
       463409 DDC; dopa decarboxylase (aromatic L-amino acid decarboxylase)
       464032 SLC18A1; solute carrier family 18 (vesicular monoamine), member 1
       466213 SLC18A2; solute carrier family 18 (vesicular monoamine), member 2
       749637 SLC18A1; solute carrier family 18 (vesicular monoamine), member 1
       466914 CACNA1C; calcium channel, voltage-dependent, L type, alpha 1C subunit
       460447 CACNA1D; calcium channel, voltage-dependent, L type, alpha 1D subunit
       465629 CACNA1F; calcium channel, voltage-dependent, L type, alpha 1F subunit
       740711 voltage-dependent L-type calcium channel subunit alpha-1F-like
       469635 CACNA1S; calcium channel, voltage-dependent, L type, alpha 1S subunit
       467355 HTR2A; 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
       737647 HTR2B; 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
       473740 HTR2C; 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
       472962 GNAQ; guanine nucleotide binding protein (G protein), q polypeptide
       453330 PLCB2; phospholipase C, beta 2
       458093 PLCB4; phospholipase C, beta 4
       469875 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific)
       451290 PLCB3; phospholipase C, beta 3 (phosphatidylinositol-specific)
       460134 ITPR1; inositol 1,4,5-trisphosphate receptor, type 1
       473389 ITPR2; inositol 1,4,5-trisphosphate receptor, type 2
       462618 ITPR3; inositol 1,4,5-trisphosphate receptor, type 3
       454832 PRKCA; protein kinase C, alpha
       456276 PRKCG; protein kinase C, gamma
       453993 PRKCB; protein kinase C, beta
       454037 MAPK3; mitogen-activated protein kinase 3
       458680 MAPK1; mitogen-activated protein kinase 1
       467664 PLA2G4E; phospholipase A2, group IVE
       469617 PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent)
       453706 cytosolic phospholipase A2 beta-like
       747584 PLA2G4B; phospholipase A2, group IVB (cytosolic)
       468935 PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent)
       100610135 PLA2G4D; phospholipase A2, group IVD (cytosolic)
       453356 PLA2G4F; phospholipase A2, group IVF
       739598 PLA2G4B; phospholipase A2, group IVB
       749457 PLA2G4B; phospholipase A2, group IVB
       739798 PLA2G4B; phospholipase A2, group IVB
       740368 PLA2G4B; phospholipase A2, group IVB
       748705 PLA2G4B; phospholipase A2, group IVB
       450909 CYP2C8; cytochrome P450, family 2, subfamily C, polypeptide 8
       100616515 cytochrome P450 2C9-like
       740956 cytochrome P450 2C19-like
       470228 CYP2D6; cytochrome P450, family 2, subfamily D, polypeptide 6 
       456896 cytochrome P450 2J2-like
       456833 cytochrome P450 4X1-like
       450428 ALOX5; arachidonate 5-lipoxygenase
       455242 ALOX12; arachidonate 12-lipoxygenase
       455243 arachidonate 12-lipoxygenase
       455103 ALOX12B; arachidonate 12-lipoxygenase, 12R type
       748294 ALOX15; arachidonate 15-lipoxygenase
       455104 ALOX15B; arachidonate 15-lipoxygenase, type B
       464713 PTGS1; prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       451556 HTR3A; 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
       471023 HTR3E; 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
       471020 HTR3D; 5-hydroxytryptamine (serotonin) receptor 3 family member D
       471021 HTR3C; 5-hydroxytryptamine (serotonin) receptor 3C, ionotropic
       466788 HTR3B; 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic
       462175 HTR4; 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
       469199 HTR6; 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
       466154 HTR7; 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
       469986 GNAS; GNAS complex locus
       470905 ADCY5; adenylate cyclase 5
       469367 PRKACB; protein kinase, cAMP-dependent, catalytic, beta
       472944 PRKACG; protein kinase, cAMP-dependent, catalytic, gamma
       449495 PRKX; protein kinase, X-linked 
       455776 PRKACA; protein kinase, cAMP-dependent, catalytic, alpha
       751063 cAMP-dependent protein kinase catalytic subunit PRKX-like
       462006 KCNN2; potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
       472489 KCND2; potassium voltage-gated channel, Shal-related subfamily, member 2
       461352 GABRB1; gamma-aminobutyric acid (GABA) A receptor, beta 1
       453265 GABRB3; gamma-aminobutyric acid (GABA) A receptor, beta 3
       462240 GABRB2; gamma-aminobutyric acid (GABA) A receptor, beta 2
       467198 RAPGEF3; Rap guanine nucleotide exchange factor (GEF) 3
       473931 APP; amyloid beta (A4) precursor protein
       471533 HTR1A; 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
       462833 HTR1B; 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
       469219 HTR1D; 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
       470863 HTR1F; 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled
       472064 HTR1E; 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled
       463837 HTR5A; 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled
       470518 5-hydroxytryptamine receptor 5B-like
       457093 GNAI3; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
       472425 GNAI1; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
       744773 GNAI2; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
       450173 GNAO1; guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
       469458 GNB1; guanine nucleotide binding protein (G protein), beta polypeptide 1
       739897 GNB2; guanine nucleotide binding protein (G protein), beta polypeptide 2
       100612078 GNB3; guanine nucleotide binding protein (G protein), beta polypeptide 3
       460862 GNB4; guanine nucleotide binding protein (G protein), beta polypeptide 4
       745402 GNB5; guanine nucleotide binding protein (G protein), beta 5
       467457 GNG2; guanine nucleotide binding protein (G protein), gamma 2
       740869 GNG3; guanine nucleotide binding protein (G protein), gamma 3
       743331 GNG4; guanine nucleotide binding protein (G protein), gamma 4
       456977 GNG5; guanine nucleotide binding protein (G protein), gamma 5
       744391 GNG7; guanine nucleotide binding protein (G protein), gamma 7
       100608423 uncharacterized LOC100608423
       100611518 uncharacterized LOC100611518
       747185 GNG11; guanine nucleotide binding protein (G protein), gamma 11
       100609242 GNG12; guanine nucleotide binding protein (G protein), gamma 12
       468737 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7-like
       749882 GNG13; guanine nucleotide binding protein (G protein), gamma 13
       747170 GNGT1; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1
       749133 GNGT2; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2
       461669 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       466302 HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog
       473387 KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
       742713 NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog
       100614256 ARAF; v-raf murine sarcoma 3611 viral oncogene homolog
       463781 BRAF; v-raf murine sarcoma viral oncogene homolog B1
       460182 RAF1; v-raf-1 murine leukemia viral oncogene homolog 1
       450188 MAP2K1; mitogen-activated protein kinase kinase 1 
       455766 CACNA1A; calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
       464893 CACNA1B; calcium channel, voltage-dependent, N type, alpha 1B subunit
       737029 KCNJ3; potassium inwardly-rectifying channel, subfamily J, member 3
       474111 KCNJ6; potassium inwardly-rectifying channel, subfamily J, member 6
       469548 KCNJ9; potassium inwardly-rectifying channel, subfamily J, member 9
       451660 KCNJ5; potassium inwardly-rectifying channel, subfamily J, member 5
       460747 TRPC1; transient receptor potential cation channel, subfamily C, member 1
       468201 SLC6A4; solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
       740491 MAOA; monoamine oxidase A
       465588 MAOB; monoamine oxidase B
       743285 amine oxidase [flavin-containing] A-like
K00502 TPH1_2; tryptophan 5-monooxygenase [EC:1.14.16.4]
K00502 TPH1_2; tryptophan 5-monooxygenase [EC:1.14.16.4]
K01593 DDC; aromatic-L-amino-acid decarboxylase [EC:4.1.1.28]
K08155 SLC18A1_2; MFS transporter, DHA1 family, solute carrier family 18 (vesicular amine transporter), member 1/2
K08155 SLC18A1_2; MFS transporter, DHA1 family, solute carrier family 18 (vesicular amine transporter), member 1/2
K08155 SLC18A1_2; MFS transporter, DHA1 family, solute carrier family 18 (vesicular amine transporter), member 1/2
K04850 CACNA1C; voltage-dependent calcium channel L type alpha-1C
K04851 CACNA1D; voltage-dependent calcium channel L type alpha-1D
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04857 CACNA1S; voltage-dependent calcium channel L type alpha-1S
K04157 HTR2; 5-hydroxytryptamine receptor 2
K04157 HTR2; 5-hydroxytryptamine receptor 2
K04157 HTR2; 5-hydroxytryptamine receptor 2
K04634 GNAQ; guanine nucleotide-binding protein G(q) subunit alpha
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K17718 CYP2C8; cytochrome P450, family 2, subfamily C, polypeptide 8 [EC:1.14.14.1]
K17719 CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9 [EC:1.14.13.48 1.14.13.49 1.14.13.80 1.14.13.-]
K17721 CYP2C19; cytochrome P450, family 2, subfamily C, polypeptide 19 [EC:1.14.13.48 1.14.13.49 1.14.13.80 1.14.13.-]
K17712 CYP2D6; cytochrome P450, family 2, subfamily D, polypeptide 6 [EC:1.14.14.1]
K07418 CYP2J; cytochrome P450, family 2, subfamily J [EC:1.14.14.1]
K07428 CYP4X; cytochrome P450, family 4, subfamily X [EC:1.14.14.1]
K00461 ALOX5; arachidonate 5-lipoxygenase [EC:1.13.11.34]
K00458 ALOX12; arachidonate 12-lipoxygenase [EC:1.13.11.31]
K00458 ALOX12; arachidonate 12-lipoxygenase [EC:1.13.11.31]
K08021 ALOX12B; arachidonate 12-lipoxygenase (R-type) [EC:1.13.11.-]
K00460 ALOX15; arachidonate 15-lipoxygenase [EC:1.13.11.33]
K08022 ALOX15B; arachidonate 15-lipoxygenase (second type) / 8-lipoxygenase (S-type) [EC:1.13.11.33 1.13.11.-]
K00509 PTGS1; prostaglandin-endoperoxide synthase 1 [EC:1.14.99.1]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K04819 HTR3; 5-hydroxytryptamine receptor 3
K04819 HTR3; 5-hydroxytryptamine receptor 3
K04819 HTR3; 5-hydroxytryptamine receptor 3
K04819 HTR3; 5-hydroxytryptamine receptor 3
K04819 HTR3; 5-hydroxytryptamine receptor 3
K04160 HTR4; 5-hydroxytryptamine receptor 4
K04162 HTR6; 5-hydroxytryptamine receptor 6
K04163 HTR7; 5-hydroxytryptamine receptor 7
K04632 GNAS; guanine nucleotide-binding protein G(s) subunit alpha
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04943 KCNN2; potassium intermediate/small conductance calcium-activated channel subfamily N member 2
K04892 KCND2; potassium voltage-gated channel Shal-related subfamily D member 2
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K08014 RAPGEF3; Rap guanine nucleotide exchange factor 3
K04520 APP; amyloid beta A4 protein
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04161 HTR5; 5-hydroxytryptamine receptor 5
K04161 HTR5; 5-hydroxytryptamine receptor 5
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04534 GNAO; guanine nucleotide-binding protein G(o) subunit alpha
K04536 GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
K04537 GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2
K07825 GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3
K04538 GNB4; guanine nucleotide-binding protein subunit beta-4
K04539 GNB5; guanine nucleotide-binding protein subunit beta-5
K07826 GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
K04540 GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3
K04541 GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4
K04542 GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5
K04543 GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7
K04544 GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8
K04545 GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10
K04546 GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11
K04347 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
K04347 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
K04547 GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13
K04548 GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1
K04549 GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K08845 ARAF; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04344 CACNA1A; voltage-dependent calcium channel P/Q type alpha-1A
K04849 CACNA1B; voltage-dependent calcium channel N type alpha-1B
K04997 KCNJ3; potassium inwardly-rectifying channel subfamily J member 3
K05000 KCNJ6; potassium inwardly-rectifying channel subfamily J member 6
K05002 KCNJ9; potassium inwardly-rectifying channel subfamily J member 9
K04999 KCNJ5; potassium inwardly-rectifying channel subfamily J member 5
K04964 TRPC1; transient receptor potential cation channel subfamily C member 1
K05037 SLC6A4; solute carrier family 6 (neurotransmitter transporter, serotonin) member 4
K00274 MAO; monoamine oxidase [EC:1.4.3.4]
K00274 MAO; monoamine oxidase [EC:1.4.3.4]
K00274 MAO; monoamine oxidase [EC:1.4.3.4]
     04720 Long-term potentiation [PATH:ptr04720]
     04730 Long-term depression [PATH:ptr04730]
     04723 Retrograde endocannabinoid signaling [PATH:ptr04723]
       452161 SLC17A8; solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8
       100610704 SLC17A6; solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6
       456204 SLC17A7; solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7
       471714 GRIA1; glutamate receptor, ionotropic, AMPA 1
       461570 GRIA2; glutamate receptor, ionotropic, AMPA 2
       465842 GRIA3; glutamate receptor, ionotropic, AMPA 3
       466768 GRIA4; glutamate receptor, ionotropic, AMPA 4
       466914 CACNA1C; calcium channel, voltage-dependent, L type, alpha 1C subunit
       460447 CACNA1D; calcium channel, voltage-dependent, L type, alpha 1D subunit
       465629 CACNA1F; calcium channel, voltage-dependent, L type, alpha 1F subunit
       740711 voltage-dependent L-type calcium channel subunit alpha-1F-like
       469635 CACNA1S; calcium channel, voltage-dependent, L type, alpha 1S subunit
       463049 GRM1; glutamate receptor, metabotropic 1
       451472 GRM5; glutamate receptor, metabotropic 5
       472962 GNAQ; guanine nucleotide binding protein (G protein), q polypeptide
       453330 PLCB2; phospholipase C, beta 2
       458093 PLCB4; phospholipase C, beta 4
       469875 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific)
       451290 PLCB3; phospholipase C, beta 3 (phosphatidylinositol-specific)
       460134 ITPR1; inositol 1,4,5-trisphosphate receptor, type 1
       473389 ITPR2; inositol 1,4,5-trisphosphate receptor, type 2
       462618 ITPR3; inositol 1,4,5-trisphosphate receptor, type 3
       472476 NAPEPLD; N-acyl phosphatidylethanolamine phospholipase D
       454832 PRKCA; protein kinase C, alpha
       456276 PRKCG; protein kinase C, gamma
       453993 PRKCB; protein kinase C, beta
       451241 DAGLA; diacylglycerol lipase, alpha
       472286 DAGLB; diacylglycerol lipase, beta
       100612262 sn1-specific diacylglycerol lipase beta-like
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       470830 ABHD6; abhydrolase domain containing 6
       456559 FAAH; fatty acid amide hydrolase
       472066 CNR1; cannabinoid receptor 1 (brain)
       457093 GNAI3; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
       472425 GNAI1; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
       744773 GNAI2; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
       450173 GNAO1; guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
       469458 GNB1; guanine nucleotide binding protein (G protein), beta polypeptide 1
       739897 GNB2; guanine nucleotide binding protein (G protein), beta polypeptide 2
       100612078 GNB3; guanine nucleotide binding protein (G protein), beta polypeptide 3
       460862 GNB4; guanine nucleotide binding protein (G protein), beta polypeptide 4
       745402 GNB5; guanine nucleotide binding protein (G protein), beta 5
       467457 GNG2; guanine nucleotide binding protein (G protein), gamma 2
       740869 GNG3; guanine nucleotide binding protein (G protein), gamma 3
       743331 GNG4; guanine nucleotide binding protein (G protein), gamma 4
       456977 GNG5; guanine nucleotide binding protein (G protein), gamma 5
       744391 GNG7; guanine nucleotide binding protein (G protein), gamma 7
       100608423 uncharacterized LOC100608423
       100611518 uncharacterized LOC100611518
       747185 GNG11; guanine nucleotide binding protein (G protein), gamma 11
       100609242 GNG12; guanine nucleotide binding protein (G protein), gamma 12
       468737 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7-like
       749882 GNG13; guanine nucleotide binding protein (G protein), gamma 13
       747170 GNGT1; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1
       749133 GNGT2; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2
       737029 KCNJ3; potassium inwardly-rectifying channel, subfamily J, member 3
       474111 KCNJ6; potassium inwardly-rectifying channel, subfamily J, member 6
       469548 KCNJ9; potassium inwardly-rectifying channel, subfamily J, member 9
       451660 KCNJ5; potassium inwardly-rectifying channel, subfamily J, member 5
       455766 CACNA1A; calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
       464893 CACNA1B; calcium channel, voltage-dependent, N type, alpha 1B subunit
       454037 MAPK3; mitogen-activated protein kinase 3
       458680 MAPK1; mitogen-activated protein kinase 1
       450445 MAPK8; mitogen-activated protein kinase 8
       461358 MAPK10; mitogen-activated protein kinase 10
       462336 MAPK9; mitogen-activated protein kinase 9
       450161 MAPK14; mitogen-activated protein kinase 14 
       462644 MAPK13; mitogen-activated protein kinase 13 
       747077 MAPK12; mitogen-activated protein kinase 12
       463392 ADCY1; adenylate cyclase 1 (brain)
       461715 ADCY2; adenylate cyclase 2
       459070 ADCY3; adenylate cyclase 3
       452819 ADCY4; adenylate cyclase 4
       470905 ADCY5; adenylate cyclase 5
       451866 ADCY6; adenylate cyclase 6
       473278 ADCY7; adenylate cyclase 7
       464400 ADCY8; adenylate cyclase 8 (brain)
       100615296 adenylate cyclase type 8-like
       453869 ADCY9; adenylate cyclase 9
       469367 PRKACB; protein kinase, cAMP-dependent, catalytic, beta
       472944 PRKACG; protein kinase, cAMP-dependent, catalytic, gamma
       449495 PRKX; protein kinase, X-linked 
       455776 PRKACA; protein kinase, cAMP-dependent, catalytic, alpha
       751063 cAMP-dependent protein kinase catalytic subunit PRKX-like
       739167 MGLL; monoglyceride lipase
       469940 SLC32A1; solute carrier family 32 (GABA vesicular transporter), member 1
       472054 RIMS1; regulating synaptic membrane exocytosis 1
       462241 GABRA1; gamma-aminobutyric acid (GABA) A receptor, alpha 1
       461355 GABRA2; gamma-aminobutyric acid (GABA) A receptor, alpha 2
       465914 GABRA3; gamma-aminobutyric acid (GABA) A receptor, alpha 3
       471392 GABRA4; gamma-aminobutyric acid (GABA) A receptor, alpha 4
       471725 GABRA6; gamma-aminobutyric acid (GABA) A receptor, alpha 6
       461352 GABRB1; gamma-aminobutyric acid (GABA) A receptor, beta 1
       453265 GABRB3; gamma-aminobutyric acid (GABA) A receptor, beta 3
       462240 GABRB2; gamma-aminobutyric acid (GABA) A receptor, beta 2
       471393 GABRG1; gamma-aminobutyric acid (GABA) A receptor, gamma 1
       462242 GABRG2; gamma-aminobutyric acid (GABA) A receptor, gamma 2
       747186 GABRD; gamma-aminobutyric acid (GABA) A receptor, delta
       465911 GABRE; gamma-aminobutyric acid (GABA) A receptor, epsilon
       736978 GABRQ; gamma-aminobutyric acid (GABA) A receptor, theta
       471736 GABRP; gamma-aminobutyric acid (GABA) A receptor, pi
       472068 GABRR1; gamma-aminobutyric acid (GABA) A receptor, rho 1
       472069 GABRR2; gamma-aminobutyric acid (GABA) A receptor, rho 2
       470869 GABRR3; gamma-aminobutyric acid (GABA) A receptor, rho 3
K12302 SLC17A6_7_8; MFS transporter, ACS family, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6/7/8
K12302 SLC17A6_7_8; MFS transporter, ACS family, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6/7/8
K12302 SLC17A6_7_8; MFS transporter, ACS family, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6/7/8
K05197 GRIA1; glutamate receptor 1
K05198 GRIA2; glutamate receptor 2
K05199 GRIA3; glutamate receptor 3
K05200 GRIA4; glutamate receptor 4
K04850 CACNA1C; voltage-dependent calcium channel L type alpha-1C
K04851 CACNA1D; voltage-dependent calcium channel L type alpha-1D
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04857 CACNA1S; voltage-dependent calcium channel L type alpha-1S
K04603 GRM1; metabotropic glutamate receptor 1
K04604 GRM5; metabotropic glutamate receptor 5
K04634 GNAQ; guanine nucleotide-binding protein G(q) subunit alpha
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K13985 NAPEPLD; N-acyl-phosphatidylethanolamine-hydrolysing phospholipase D [EC:3.1.4.54]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K13806 DAGL; sn1-specific diacylglycerol lipase [EC:3.1.1.-]
K13806 DAGL; sn1-specific diacylglycerol lipase [EC:3.1.1.-]
K13806 DAGL; sn1-specific diacylglycerol lipase [EC:3.1.1.-]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K13700 ABHD6; abhydrolase domain-containing protein 6 [EC:3.1.1.23]
K15528 FAAH; fatty acid amide hydrolase [EC:3.5.1.99]
K04277 CNR1; cannabinoid receptor 1
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04534 GNAO; guanine nucleotide-binding protein G(o) subunit alpha
K04536 GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
K04537 GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2
K07825 GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3
K04538 GNB4; guanine nucleotide-binding protein subunit beta-4
K04539 GNB5; guanine nucleotide-binding protein subunit beta-5
K07826 GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
K04540 GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3
K04541 GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4
K04542 GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5
K04543 GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7
K04544 GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8
K04545 GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10
K04546 GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11
K04347 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
K04347 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
K04547 GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13
K04548 GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1
K04549 GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2
K04997 KCNJ3; potassium inwardly-rectifying channel subfamily J member 3
K05000 KCNJ6; potassium inwardly-rectifying channel subfamily J member 6
K05002 KCNJ9; potassium inwardly-rectifying channel subfamily J member 9
K04999 KCNJ5; potassium inwardly-rectifying channel subfamily J member 5
K04344 CACNA1A; voltage-dependent calcium channel P/Q type alpha-1A
K04849 CACNA1B; voltage-dependent calcium channel N type alpha-1B
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K08041 ADCY1; adenylate cyclase 1 [EC:4.6.1.1]
K08042 ADCY2; adenylate cyclase 2 [EC:4.6.1.1]
K08043 ADCY3; adenylate cyclase 3 [EC:4.6.1.1]
K08044 ADCY4; adenylate cyclase 4 [EC:4.6.1.1]
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K08046 ADCY6; adenylate cyclase 6 [EC:4.6.1.1]
K08047 ADCY7; adenylate cyclase 7 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08049 ADCY9; adenylate cyclase 9 [EC:4.6.1.1]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K01054 MGLL; acylglycerol lipase [EC:3.1.1.23]
K15015 SLC32A; solute carrier family 32 (vesicular inhibitory amino acid transporter)
K15291 RIMS1; regulating synaptic membrane exocytosis protein 1
K05175 GABRA; gamma-aminobutyric acid receptor subunit alpha
K05175 GABRA; gamma-aminobutyric acid receptor subunit alpha
K05175 GABRA; gamma-aminobutyric acid receptor subunit alpha
K05175 GABRA; gamma-aminobutyric acid receptor subunit alpha
K05175 GABRA; gamma-aminobutyric acid receptor subunit alpha
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K05186 GABRG; gmma-aminobutyric acid receptor subunit gamma
K05186 GABRG; gmma-aminobutyric acid receptor subunit gamma
K05184 GABRD; gamma-aminobutyric acid receptor subunit delta
K05185 GABRE; gamma-aminobutyric acid receptor subunit epsilon
K05192 GABRQ; gamma-aminobutyric acid receptor subunit theta
K05189 GABRP; gamma-aminobutyric acid receptor subunit pi
K05190 GABRR; gamma-aminobutyric acid receptor subunit rho
K05190 GABRR; gamma-aminobutyric acid receptor subunit rho
K05190 GABRR; gamma-aminobutyric acid receptor subunit rho
     04721 Synaptic vesicle cycle [PATH:ptr04721]
     04722 Neurotrophin signaling pathway [PATH:ptr04722]
 
   Sensory system
 
   Development
 
   Environmental adaptation
 
 Human Diseases
 
   Cancers
     05200 Pathways in cancer [PATH:ptr05200]
       455425 DCC; deleted in colorectal carcinoma
       461669 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       456457 CASP9; caspase 9, apoptosis-related cysteine peptidase
       460469 APPL1; adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
       468009 CDH1; cadherin 1, type 1, E-cadherin (epithelial)
       450183 CTNNB1; catenin (cadherin-associated protein), beta 1, 88kDa
       450165 CTNNA1; catenin (cadherin-associated protein), alpha 1, 102kDa
       459352 CTNNA2; catenin (cadherin-associated protein), alpha 2
       746091 CTNNA3; catenin (cadherin-associated protein), alpha 3
       453789 AXIN1; axin 1
       468301 AXIN2; axin 2
       461999 APC; adenomatous polyposis coli
       455551 APC2; adenomatosis polyposis coli 2
       100616510 GSK3B; glycogen synthase kinase 3 beta
       745839 TCF7; transcription factor 7 (T-cell specific, HMG-box)
       744526 TCF7L1; transcription factor 7-like 1 (T-cell specific, HMG-box)
       450743 TCF7L2; transcription factor 7-like 2 (T-cell specific, HMG-box)
       461425 LEF1; lymphoid enhancer-binding factor 1
       455276 BIRC5; baculoviral IAP repeat containing 5
       464393 MYC; v-myc myelocytomatosis viral oncogene homolog (avian)
       747688 CCND1; cyclin D1
       742674 WNT1; wingless-type MMTV integration site family, member 1
       463673 WNT2; wingless-type MMTV integration site family member 2
       457103 WNT2B; wingless-type MMTV integration site family, member 2B
       468297 WNT3; wingless-type MMTV integration site family, member 3
       100615247 WNT3A; wingless-type MMTV integration site family, member 3A
       469212 WNT4; wingless-type MMTV integration site family, member 4
       467191 WNT5B; wingless-type MMTV integration site family, member 5B
       460458 WNT5A; wingless-type MMTV integration site family, member 5A
       742467 WNT6; wingless-type MMTV integration site family, member 6
       465393 WNT7B; wingless-type MMTV integration site family, member 7B
       471645 WNT8A; wingless-type MMTV integration site family, member 8A
       466182 WNT8B; wingless-type MMTV integration site family, member 8B
       468296 WNT9B; wingless-type MMTV integration site family, member 9B
       469697 WNT9A; wingless-type MMTV integration site family, member 9A
       451870 WNT10B; wingless-type MMTV integration site family, member 10B
       459952 WNT10A; wingless-type MMTV integration site family, member 10A
       451431 WNT11; wingless-type MMTV integration site family, member 11
       737375 WNT16; wingless-type MMTV integration site family, member 16
       463524 FZD1; frizzled family receptor 1
       459881 FZD7; frizzled family receptor 7
       454731 FZD2; frizzled family receptor 2
       472726 FZD3; frizzled family receptor 3
       466732 FZD4; frizzled family receptor 4
       470627 FZD5; frizzled family receptor 5
       466040 FZD8; frizzled family receptor 8
       464327 FZD6; frizzled family receptor 6
       467160 FZD10; frizzled family receptor 10
       472405 FZD9; frizzled family receptor 9
       460882 DVL3; dishevelled, dsh homolog 3 (Drosophila)
       455236 DVL2; dishevelled, dsh homolog 2 (Drosophila)
       457191 DVL1; dishevelled, dsh homolog 1 (Drosophila)
       452659 COL4A1; collagen, type IV, alpha 1
       459986 COL4A4; collagen, type IV, alpha 4
       465804 COL4A6; collagen, type IV, alpha 6
       452661 COL4A2; collagen, type IV, alpha 2
       459988 COL4A3; collagen, type IV, alpha 3 (Goodpasture antigen)
       465805 COL4A5; collagen, type IV, alpha 5
       455302 LAMA1; laminin, alpha 1
       472122 LAMA2; laminin, alpha 2
       455339 LAMA3; laminin, alpha 3
       458387 LAMA5; laminin, alpha 5
       462946 LAMA4; laminin, alpha 4
       463656 LAMB1; laminin, beta 1
       460365 LAMB2; laminin, beta 2 (laminin S)
       469668 LAMB3; laminin, beta 3
       463657 LAMB4; laminin, beta 4
       457570 LAMC1; laminin, gamma 1 (formerly LAMB2)
       457571 LAMC2; laminin, gamma 2
       100611162 LAMC3; laminin, gamma 3
       464805 laminin subunit gamma-3-like
       459926 FN1; fibronectin 1
       471550 ITGA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
       454730 ITGA2B; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
       455111 ITGA3; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
       459742 ITGA6; integrin, alpha 6
       459807 ITGAV; integrin, alpha V
       450396 ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
       464422 PTK2; PTK2 protein tyrosine kinase 2
       463649 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
       460858 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
       457922 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
       471079 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
       456565 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       461836 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       455085 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       455855 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       466142 PTEN; phosphatase and tensin homolog
       743612 NKX3-1; NK3 homeobox 1
       456035 AKT2; v-akt murine thymoma viral oncogene homolog 2
       740898 AKT1; v-akt murine thymoma viral oncogene homolog 1
       100609583 AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) 
       450673 CHUK; conserved helix-loop-helix ubiquitous kinase 
       472749 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
       100610002 NF-kappa-B essential modulator-like
       467426 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       461406 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       450697 NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
       466665 RELA; v-rel reticuloendotheliosis viral oncogene homolog A (avian)
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       455026 NOS2; nitric oxide synthase 2, inducible
       738409 BCL2; B-cell CLL/lymphoma 2
       451508 BIRC2; baculoviral IAP repeat containing 2
       451507 BIRC3; baculoviral IAP repeat containing 3
       473765 XIAP; X-linked inhibitor of apoptosis
       746160 BIRC7; baculoviral IAP repeat containing 7
       450113 BIRC8; baculoviral IAP repeat containing 8
       458156 BCL2L1; BCL2-like 1
       743748 TRAF1; TNF receptor-associated factor 1
       464876 TRAF2; TNF receptor-associated factor 2
       453178 TRAF3; TNF receptor-associated factor 3
       454534 TRAF4; TNF receptor-associated factor 4
       457711 TRAF5; TNF receptor-associated factor 5
       451702 TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase
       457945 MTOR; mechanistic target of rapamycin (serine/threonine kinase)
       100615623 BAD; BCL2-associated agonist of cell death
       467352 FOXO1; forkhead box O1
       742141 MDM2; Mdm2, p53 E3 ubiquitin protein ligase homolog (mouse)
       455214 TP53; tumor protein p53
       466947 CDKN1B; cyclin-dependent kinase inhibitor 1B (p27, Kip1)
       747442 CDKN1A; cyclin-dependent kinase inhibitor 1A (p21, Cip1)
       458694 BCR; breakpoint cluster region
       464802 ABL1; c-abl oncogene 1, non-receptor tyrosine kinase
       470146 CRKL; v-crk sarcoma virus CT10 oncogene homolog (avian)-like
       747142 CRK; v-crk sarcoma virus CT10 oncogene homolog (avian)
       451690 CBL; Cbl proto-oncogene, E3 ubiquitin protein ligase
       460566 CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B
       456117 CBLC; Cbl proto-oncogene, E3 ubiquitin protein ligase C
       454681 STAT5A; signal transducer and activator of transcription 5A
       454679 STAT5B; signal transducer and activator of transcription 5B
       743373 JAK1; Janus kinase 1
       454682 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor)
       459834 STAT1; signal transducer and activator of transcription 1, 91kDa
       741897 VEGFB; vascular endothelial growth factor B
       741830 PGF; placental growth factor
       471358 VEGFC; vascular endothelial growth factor C
       465508 FIGF; c-fos induced growth factor (vascular endothelial growth factor D)
       737080 TGFA; transforming growth factor, alpha
       461435 EGF; epidermal growth factor
       463415 EGFR; epidermal growth factor receptor
       454636 ERBB2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
       740202 PDGFA; platelet-derived growth factor alpha polypeptide
       458844 PDGFB; platelet-derived growth factor beta polypeptide
       461318 PDGFRA; platelet-derived growth factor receptor, alpha polypeptide
       462188 PDGFRB; platelet-derived growth factor receptor, beta polypeptide
       741055 IGF1; insulin-like growth factor 1 (somatomedin C)
       453676 IGF1R; insulin-like growth factor 1 receptor
       452114 KITLG; KIT ligand
       461316 KIT; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
       100610021 FLT3LG; fms-related tyrosine kinase 3 ligand
       452508 FLT3; fms-related tyrosine kinase 3
       463503 HGF; hepatocyte growth factor (hepapoietin A; scatter factor)
       463671 MET; met proto-oncogene (hepatocyte growth factor receptor) 
       462158 FGF1; fibroblast growth factor 1 (acidic)
       641462 FGF2; fibroblast growth factor 2 (basic)
       747181 FGF6; fibroblast growth factor 6
       747164 FGF23; fibroblast growth factor 23
       471041 FGF12; fibroblast growth factor 12
       468948 FGF21; fibroblast growth factor 21
       472708 FGF17; fibroblast growth factor 17
       471553 FGF10; fibroblast growth factor 10
       465886 FGF13; fibroblast growth factor 13
       468631 FGF22; fibroblast growth factor 22
       744975 FGF7; fibroblast growth factor 7
       473676 FGF16; fibroblast growth factor 16
       471190 FGF5; fibroblast growth factor 5
       748965 FGF11; fibroblast growth factor 11
       739611 FGF18; fibroblast growth factor 18
       747727 FGF4; fibroblast growth factor 4
       466693 FGF3; fibroblast growth factor 3
       739665 FGF20; fibroblast growth factor 20
       739338 FGF14; fibroblast growth factor 14
       744731 FGF9; fibroblast growth factor 9 (glia-activating factor)
       101056934 FGF8; fibroblast growth factor 8 (androgen-induced)
       747710 FGF19; fibroblast growth factor 19
       464122 FGFR1; fibroblast growth factor receptor 1
       466220 FGFR2; fibroblast growth factor receptor 2
       461067 FGFR3; fibroblast growth factor receptor 3
       737245 GRB2; growth factor receptor-bound protein 2
       459171 SOS1; son of sevenless homolog 1 (Drosophila)
       452897 SOS2; son of sevenless homolog 2 (Drosophila)
       466302 HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog
       473387 KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
       742713 NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog
       100614256 ARAF; v-raf murine sarcoma 3611 viral oncogene homolog
       463781 BRAF; v-raf murine sarcoma viral oncogene homolog B1
       460182 RAF1; v-raf-1 murine leukemia viral oncogene homolog 1
       450188 MAP2K1; mitogen-activated protein kinase kinase 1 
       456390 MAP2K2; mitogen-activated protein kinase kinase 2
       100611792 dual specificity mitogen-activated protein kinase kinase 2-like
       454037 MAPK3; mitogen-activated protein kinase 3
       458680 MAPK1; mitogen-activated protein kinase 1
       456893 JUN; jun proto-oncogene
       453047 FOS; FBJ murine osteosarcoma viral oncogene homolog
       451510 MMP1; matrix metallopeptidase 1 (interstitial collagenase)
       454094 MMP2; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
       458294 MMP9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
       471205 IL8; interleukin 8
       452025 CDK4; cyclin-dependent kinase 4
       100612888 RET; ret proto-oncogene
       466080 CCDC6; coiled-coil domain containing 6
       450455 NCOA4; nuclear receptor coactivator 4
       457408 NTRK1; neurotrophic tyrosine kinase, receptor, type 1
       458000 TPM3; tropomyosin 3
       101058464 tropomyosin alpha-3 chain-like
       457588 TPR; translocated promoter region, nuclear basket protein
       460557 TFG; TRK-fused gene
       744944 RASSF1; Ras association (RalGDS/AF-6) domain family member 1
       743977 RASSF5; Ras association (RalGDS/AF-6) domain family 5
       458275 STK4; serine/threonine kinase 4 
       455594 DAPK3; death-associated protein kinase 3 
       464571 DAPK1; death-associated protein kinase 1
       747631 DAPK2; death-associated protein kinase 2
       458253 PLCG1; phospholipase C, gamma 1
       454268 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific)
       454832 PRKCA; protein kinase C, alpha
       456276 PRKCG; protein kinase C, gamma
       453993 PRKCB; protein kinase C, beta
       464824 RALGDS; ral guanine nucleotide dissociation stimulator
       737424 RALA; v-ral simian leukemia viral oncogene homolog A (ras related)
       750044 RALB; v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)
       455292 RALBP1; ralA binding protein 1
       745248 CDC42; cell division cycle 42
       456609 CDC42; cell division cycle 42 (GTP binding protein, 25kDa)
       741907 RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
       742575 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
       747131 uncharacterized LOC747131
       461014 RHOA; ras homolog family member A
       450445 MAPK8; mitogen-activated protein kinase 8
       461358 MAPK10; mitogen-activated protein kinase 10
       462336 MAPK9; mitogen-activated protein kinase 9
       459503 PAX8; paired box 8
       460178 PPARG; peroxisome proliferator-activated receptor gamma
       464834 RXRA; retinoid X receptor, alpha
       462601 RXRB; retinoid X receptor, beta
       457476 RXRG; retinoid X receptor, gamma
       745516 RARB; retinoic acid receptor, beta
       463188 PPARD; peroxisome proliferator-activated receptor delta
       454667 JUP; junction plakoglobin
       100614588 ZBTB16; zinc finger and BTB domain containing 16
       453736 PML; promyelocytic leukemia
       454647 RARA; retinoic acid receptor, alpha
       101058316 RUNX1; runt-related transcription factor 1
       472816 RUNX1T1; runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
       451169 SPI1; spleen focus forming virus (SFFV) proviral integration oncogene spi1
       746673 CEBPA; CCAAT/enhancer binding protein (C/EBP), alpha
       746936 CSF2RA; colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
       456756 CSF3R; colony stimulating factor 3 receptor (granulocyte)
       462187 CSF1R; colony stimulating factor 1 receptor
       463288 IL6; interleukin 6 (interferon, beta 2)
       465021 CDKN2A; cyclin-dependent kinase inhibitor 2A
       458184 E2F1; E2F transcription factor 1
       469153 E2F2; E2F transcription factor 2
       471865 E2F3; E2F transcription factor 3
       452972 MAX; MYC associated factor X
       455403 PIAS2; protein inhibitor of activated STAT, 2
       473204 CDKN2B; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
       746968 CDK6; cyclin-dependent kinase 6
       464582 CKS2; CDC28 protein kinase regulatory subunit 2
       100608937 CKS1B; cyclin-dependent kinases regulatory subunit 1
       471570 SKP2; S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
       467032 CDK2; cyclin-dependent kinase 2
       464292 CCNE2; cyclin E2
       455914 CCNE1; cyclin E1
       452715 RB1; retinoblastoma 1
       460500 MITF; microphthalmia-associated transcription factor
       456060 TGFB1; transforming growth factor, beta 1
       457742 TGFB2; transforming growth factor, beta 2
       453054 TGFB3; transforming growth factor, beta 3
       472992 TGFBR1; transforming growth factor, beta receptor 1
       460243 TGFBR2; transforming growth factor, beta receptor II (70/80kDa)
       455407 SMAD2; SMAD family member 2
       748161 SMAD3; SMAD family member 3
       468537 SMAD4; SMAD family member 4
       460837 MECOM; MDS1 and EVI1 complex locus
       450810 CTBP2; C-terminal binding protein 2
       738792 CTBP1; C-terminal binding protein 1
       464259 HDAC1; histone deacetylase 1
       748850 HDAC1; histone deacetylase 1
       462950 HDAC2; histone deacetylase 2
       747104 MLH1; mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)
       471494 MSH3; mutS homolog 3
       735384 MSH3; mutS homolog 3 (E. coli)
       459218 MSH6; mutS homolog 6 (E. coli)
       747093 BAX; BCL2-associated X protein
       452526 BRCA2; breast cancer 2, early onset
       453339 RAD51; RAD51 homolog (S. cerevisiae)
       469584 FASLG; Fas ligand (TNF superfamily, member 6)
       738331 FAS; Fas (TNF receptor superfamily, member 6)
       451389 FADD; Fas (TNFRSF6)-associated via death domain
       746477 CASP8; caspase 8, apoptosis-related cysteine peptidase
       458635 BID; BH3 interacting domain death agonist
       742456 cytochrome c-like
       738805 cytochrome c-like
       743378 cytochrome c-like
       741158 cytochrome c-like
       735325 cytochrome c-like
       737013 cytochrome c-like
       745019 cytochrome c-like
       464105 cytochrome c-like
       744779 CYCS; cytochrome c, somatic
       100613341 cytochrome c 2-like
       100610744 cytochrome c-like
       100613249 cytochrome c-like
       749769 VHL; von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
       464236 TCEB1; transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)
       750134 TCEB2; transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B)
       458860 RBX1; ring-box 1, E3 ubiquitin protein ligase
       450399 CUL2; cullin 2
       452850 EGLN3; egl nine homolog 3 (C. elegans)
       469708 EGLN1; egl nine homolog 1 (C. elegans)
       456049 EGLN2; egl nine homolog 2 (C. elegans) 
       749648 fumarate hydratase
       457851 FH; fumarate hydratase 
       746195 HIF1A; hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
       459204 EPAS1; endothelial PAS domain protein 1
       457279 ARNT; aryl hydrocarbon receptor nuclear translocator
       453583 ARNT2; aryl-hydrocarbon receptor nuclear translocator 2
       467891 CREBBP; CREB binding protein
       458862 EP300; E1A binding protein p300 
       100613619 SLC2A1; solute carrier family 2 (facilitated glucose transporter), member 1
       743371 SHH; sonic hedgehog
       465254 PTCH1; patched 1
       463718 SMO; smoothened, frizzled family receptor
       459948 STK36; serine/threonine kinase 36
       450699 SUFU; suppressor of fused homolog (Drosophila)
       100615503 GLI1; GLI family zinc finger 1
       459582 GLI2; GLI family zinc finger 2
       463369 GLI3; GLI family zinc finger 3
       458090 BMP2; bone morphogenetic protein 2
       452912 BMP4; bone morphogenetic protein 4
       461521 HHIP; hedgehog interacting protein
       469185 PTCH2; patched 2
       747460 AR; androgen receptor
       743883 HSP90AA1; heat shock protein 90kDa alpha (cytosolic), class A member 1
       737497 HSP90AB1; heat shock protein 90kDa alpha (cytosolic), class B member 1
       746963 putative heat shock protein HSP 90-beta 4-like
       461365 putative heat shock protein HSP 90-beta-3-like
       452187 HSP90B1; heat shock protein 90kDa beta (Grp94), member 1
       493182 KLK3; kallikrein 3 
K06765 DCC; deleted in colorectal carcinoma
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K04399 CASP9; caspase 9 [EC:3.4.22.62]
K08733 APPL; DCC-interacting protein 13 alpha
K05689 CDHE; cadherin 1, type 1, E-cadherin
K02105 CTNNB1; catenin beta 1
K05691 CTNNA; catenin alpha
K05691 CTNNA; catenin alpha
K05691 CTNNA; catenin alpha
K02157 AXIN1; axin 1
K04385 AXIN2; axin 2
K02085 APC; adenomatosis polyposis coli protein
K02085 APC; adenomatosis polyposis coli protein
K03083 GSK3B; glycogen synthase kinase 3 beta [EC:2.7.11.26]
K02620 TCF7; transcription factor 7
K04490 TCF7L1; transcription factor 7-like 1
K04491 TCF7L2; transcription factor 7-like 2
K04492 LEF1; lymphoid enhancer-binding factor 1
K08731 BIRC5; baculoviral IAP repeat-containing protein 5
K04377 MYC; Myc proto-oncogene protein
K04503 CCND1; cyclin D1
K03209 WNT1; wingless-type MMTV integration site family, member 1
K00182 WNT2; wingless-type MMTV integration site family, member 2
K00182 WNT2; wingless-type MMTV integration site family, member 2
K00312 WNT3; wingless-type MMTV integration site family, member 3
K00312 WNT3; wingless-type MMTV integration site family, member 3
K00408 WNT4; wingless-type MMTV integration site family, member 4
K00444 WNT5; wingless-type MMTV integration site family, member 5
K00444 WNT5; wingless-type MMTV integration site family, member 5
K00445 WNT6; wingless-type MMTV integration site family, member 6
K00572 WNT7; wingless-type MMTV integration site family, member 7
K00714 WNT8; wingless-type MMTV integration site family, member 8
K00714 WNT8; wingless-type MMTV integration site family, member 8
K01064 WNT9; wingless-type MMTV integration site family, member 9
K01064 WNT9; wingless-type MMTV integration site family, member 9
K01357 WNT10; wingless-type MMTV integration site family, member 10
K01357 WNT10; wingless-type MMTV integration site family, member 10
K01384 WNT11; wingless-type MMTV integration site family, member 11
K01558 WNT16; wingless-type MMTV integration site family, member 16
K02432 FZD1_7; frizzled 1/7
K02432 FZD1_7; frizzled 1/7
K02235 FZD2; frizzled 2
K02329 FZD3; frizzled 3
K02354 FZD4; frizzled 4
K02375 FZD5_8; frizzled 5/8
K02375 FZD5_8; frizzled 5/8
K02376 FZD6; frizzled 6
K02842 FZD9_10; frizzled 9/10
K02842 FZD9_10; frizzled 9/10
K02353 DVL; segment polarity protein dishevelled
K02353 DVL; segment polarity protein dishevelled
K02353 DVL; segment polarity protein dishevelled
K06237 COL4A; collagen, type IV, alpha
K06237 COL4A; collagen, type IV, alpha
K06237 COL4A; collagen, type IV, alpha
K06237 COL4A; collagen, type IV, alpha
K06237 COL4A; collagen, type IV, alpha
K06237 COL4A; collagen, type IV, alpha
K05637 LAMA1_2; laminin, alpha 1/2
K05637 LAMA1_2; laminin, alpha 1/2
K06240 LAMA3_5; laminin, alpha 3/5
K06240 LAMA3_5; laminin, alpha 3/5
K06241 LAMA4; laminin, alpha 4
K05636 LAMB1; laminin, beta 1
K06243 LAMB2; laminin, beta 2
K06244 LAMB3; laminin, beta 3
K06245 LAMB4; laminin, beta 4
K05635 LAMC1; laminin, gamma 1
K06246 LAMC2; laminin, gamma 2
K06247 LAMC3; laminin, gamma 3
K06247 LAMC3; laminin, gamma 3
K05717 FN1; fibronectin 1
K06481 ITGA2; integrin alpha 2
K06476 ITGA2B; integrin alpha 2B
K06482 ITGA3; integrin alpha 3
K06485 ITGA6; integrin alpha 6
K06487 ITGAV; integrin alpha V
K05719 ITGB1; integrin beta 1
K05725 PTK2; focal adhesion kinase 1 [EC:2.7.10.2]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K01110 PTEN; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]
K09348 NKX3-1; homeobox protein Nkx-3.1
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04469 NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
K04735 RELA; transcription factor p65
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K13241 NOS2; nitric-oxide synthase, inducible [EC:1.14.13.39]
K02161 BCL2; apoptosis regulator BCL-2
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K04725 XIAP; E3 ubiquitin-protein ligase XIAP
K16061 BIRC7_8; baculoviral IAP repeat-containing protein 7/8
K16061 BIRC7_8; baculoviral IAP repeat-containing protein 7/8
K04570 BCL2L1; BCL2-like 1 (apoptosis regulator Bcl-X)
K03172 TRAF1; TNF receptor-associated factor 1
K03173 TRAF2; TNF receptor-associated factor 2
K03174 TRAF3; TNF receptor-associated factor 3
K09848 TRAF4; TNF receptor-associated factor 4
K09849 TRAF5; TNF receptor-associated factor 5
K03175 TRAF6; TNF receptor-associated factor 6
K07203 FRAP; FKBP12-rapamycin complex-associated protein
K02158 BAD; BCL2-antagonist of cell death
K07201 FOXO1; forkhead box protein O1
K06643 MDM2; E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19]
K04451 TP53; tumor protein p53
K06624 CDKN1B; cyclin-dependent kinase inhibitor 1B
K06625 CDKN1A; cyclin-dependent kinase inhibitor 1A
K08878 BCR1; breakpoint cluster region protein [EC:2.7.11.1]
K06619 ABL1; abelson tyrosine-protein kinase 1 [EC:2.7.10.2]
K04438 CRK; proto-oncogene C-crk
K04438 CRK; proto-oncogene C-crk
K04707 CBL; E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
K04707 CBL; E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
K04707 CBL; E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
K11223 STAT5A; signal transducer and activator of transcription 5A
K11224 STAT5B; signal transducer and activator of transcription 5B
K11217 JAK1; Janus kinase 1 [EC:2.7.10.2]
K04692 STAT3; signal transducer and activator of transcription 3
K11220 STAT1; signal transducer and activator of transcription 1
K16858 VEGFB; vascular endothelial growth factor B
K16859 PGF; placenta growth factor
K05449 VEGFC_D; vascular endothelial growth factor C/D
K05449 VEGFC_D; vascular endothelial growth factor C/D
K08774 TGFA; transforming growth factor, alpha
K04357 EGF; epidermal growth factor
K04361 EGFR; epidermal growth factor receptor [EC:2.7.10.1]
K05083 ERBB2; receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]
K04359 PDGFA; platelet-derived growth factor subunit A
K17386 PDGFB; platelet-derived growth factor subunit B
K04363 PDGFRA; platelet-derived growth factor receptor alpha [EC:2.7.10.1]
K05089 PDGFRB; platelet-derived growth factor receptor beta [EC:2.7.10.1]
K05459 IGF1; insulin-like growth factor 1
K05087 IGF1R; insulin-like growth factor 1 receptor [EC:2.7.10.1]
K05461 KITLG; KIT ligand
K05091 KIT; proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
K05454 FLT3LG; fms-related tyrosine kinase 3 ligand
K05092 FLT3; fms-related tyrosine kinase 3 [EC:2.7.10.1]
K05460 HGF; hepatocyte growth factor
K05099 MET; proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
K18496 FGF1; fibroblast growth factor 1
K18497 FGF2; fibroblast growth factor 2
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04362 FGFR1; fibroblast growth factor receptor 1 [EC:2.7.10.1]
K05093 FGFR2; fibroblast growth factor receptor 2 [EC:2.7.10.1]
K05094 FGFR3; fibroblast growth factor receptor 3 [EC:2.7.10.1]
K04364 GRB2; growth factor receptor-binding protein 2
K03099 SOS; son of sevenless
K03099 SOS; son of sevenless
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K08845 ARAF; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04448 JUN; transcription factor AP-1
K04379 FOS; proto-oncogene protein c-fos
K01388 MMP1; matrix metalloproteinase-1 (interstitial collagenase) [EC:3.4.24.7]
K01398 MMP2; matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]
K01403 MMP9; matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
K10030 IL8; interleukin 8
K02089 CDK4; cyclin-dependent kinase 4 [EC:2.7.11.22]
K05126 RET; proto-oncogene tyrosine-protein kinase Ret [EC:2.7.10.1]
K09288 CCDC6; coiled-coil domain-containing protein 6
K09289 NCOA4; nuclear receptor coactivator 4
K03176 NTRK1; neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
K09290 TPM3; tropomyosin 3
K09290 TPM3; tropomyosin 3
K09291 TPR; nucleoprotein TPR
K09292 TFG; protein TFG
K09850 RASSF1; Ras association domain-containing protein 1
K08015 RASSF5; Ras association domain-containing protein 5
K04411 STK4; serine/threonine kinase 4
K08803 DAPK; death-associated protein kinase [EC:2.7.11.1]
K08803 DAPK; death-associated protein kinase [EC:2.7.11.1]
K08803 DAPK; death-associated protein kinase [EC:2.7.11.1]
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K08732 RALGDS; ral guanine nucleotide dissociation stimulator
K07834 RALA; Ras-related protein Ral-A
K07835 RALB; Ras-related protein Ral-B
K08773 RALBP1; RalA-binding protein 1
K04393 CDC42; cell division control protein 42
K04393 CDC42; cell division control protein 42
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K04513 RHOA; Ras homolog gene family, member A
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K09293 PAX8; paired box protein 8
K08530 NR1C3; peroxisome proliferator-activated receptor gamma
K08524 NR2B1; retinoid X receptor alpha
K08525 NR2B2; retinoid X receptor beta
K08526 NR2B3; retinoid X receptor gamma
K08528 NR1B2; retinoic acid receptor beta
K04504 NR1C2; peroxisome proliferator-activated receptor delta
K10056 JUP; junction plakoglobin
K10055 ZBTB16; zinc finger and BTB domain-containing protein 16
K10054 PML; probable transcription factor PML
K08527 NR1B1; retinoic acid receptor alpha
K08367 RUNX1; runt-related transcription factor 1
K10053 RUNX1T1; runt-related transcription factor 1; translocated to, 1
K09438 SPI1; transcription factor PU.1
K09055 CEBPA; CCAAT/enhancer binding protein (C/EBP), alpha
K05066 CSF2RA; granulocyte-macrophage colony-stimulating factor receptor alpha
K05061 CSF3R; granulocyte colony-stimulating factor receptor
K05090 CSF1R; macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
K05405 IL6; interleukin 6
K06621 CDKN2A; cyclin-dependent kinase inhibitor 2A
K17454 E2F1; transcription factor E2F1
K09389 E2F2; transcription factor E2F2
K06620 E2F3; transcription factor E2F3
K04453 MAX; Max protein
K16063 PIAS2; E3 SUMO-protein ligase PIAS2 [EC:6.3.2.-]
K04685 CDKN2B; cyclin-dependent kinase inhibitor 2B
K02091 CDK6; cyclin-dependent kinase 6 [EC:2.7.11.22]
K02219 CKS1; cyclin-dependent kinase regulatory subunit CKS1
K02219 CKS1; cyclin-dependent kinase regulatory subunit CKS1
K03875 SKP2; F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2)
K02206 CDK2; cyclin-dependent kinase 2 [EC:2.7.11.22]
K06626 CCNE; cyclin E
K06626 CCNE; cyclin E
K06618 RB1; retinoblastoma-associated protein
K09455 MITF; microphthalmia-associated transcription factor
K13375 TGFB1; transforming growth factor beta-1
K13376 TGFB2; transforming growth factor beta-2
K13377 TGFB3; transforming growth factor beta-3
K04674 TGFBR1; TGF-beta receptor type-1 [EC:2.7.11.30]
K04388 TGFBR2; TGF-beta receptor type-2 [EC:2.7.11.30]
K04500 SMAD2_3; mothers against decapentaplegic homolog 2/3
K04500 SMAD2_3; mothers against decapentaplegic homolog 2/3
K04501 SMAD4; mothers against decapentaplegic homolog 4
K04462 EVI1; ecotropic virus integration site 1 protein
K04496 CTBP; C-terminal binding protein
K04496 CTBP; C-terminal binding protein
K06067 HDAC1_2; histone deacetylase 1/2 [EC:3.5.1.98]
K06067 HDAC1_2; histone deacetylase 1/2 [EC:3.5.1.98]
K06067 HDAC1_2; histone deacetylase 1/2 [EC:3.5.1.98]
K08734 MLH1; DNA mismatch repair protein MLH1
K08736 MSH3; DNA mismatch repair protein MSH3
K08736 MSH3; DNA mismatch repair protein MSH3
K08737 MSH6; DNA mismatch repair protein MSH6
K02159 BAX; apoptosis regulator BAX
K08775 BRCA2; breast cancer 2 susceptibility protein
K04482 RAD51; DNA repair protein RAD51
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K02373 FADD; FAS-associated death domain protein
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K04726 BID; BH3 interacting domain death agonist
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K03871 VHL; von Hippel-Lindau disease tumor supressor
K03872 TCEB1; transcription elongation factor B, polypeptide 1
K03873 TCEB2; transcription elongation factor B, polypeptide 2
K03868 RBX1; RING-box protein 1
K03870 CUL2; cullin 2
K09592 EGLN; hypoxia-inducible factor prolyl hydroxylase [EC:1.14.11.29]
K09592 EGLN; hypoxia-inducible factor prolyl hydroxylase [EC:1.14.11.29]
K09592 EGLN; hypoxia-inducible factor prolyl hydroxylase [EC:1.14.11.29]
K01679 E4.2.1.2B; fumarate hydratase, class II [EC:4.2.1.2]
K01679 E4.2.1.2B; fumarate hydratase, class II [EC:4.2.1.2]
K08268 HIF1A; hypoxia-inducible factor 1 alpha
K09095 HIF2A; hypoxia-inducible factor 2 alpha
K09097 ARNT; aryl hydrocarbon receptor nuclear translocator
K15589 ARNT2; aryl hydrocarbon receptor nuclear translocator 2
K04498 EP300; E1A/CREB-binding protein [EC:2.3.1.48]
K04498 EP300; E1A/CREB-binding protein [EC:2.3.1.48]
K07299 SLC2A1; MFS transporter, SP family, solute carrier family 2 (facilitated glucose transporter), member 1
K11988 SHH; sonic hedgehog
K06225 PTCH1; patched 1
K06226 SMO; smoothened
K06228 FU; fused [EC:2.7.11.1]
K06229 SUFU; suppressor of fused
K16797 GLI1; zinc finger protein GLI1
K16798 GLI2; zinc finger protein GLI2
K06230 GLI3; zinc finger protein GLI3
K04662 BMP2_4; bone morphogenetic protein 2/4
K04662 BMP2_4; bone morphogenetic protein 2/4
K06231 HHIP; hedgehog interacting protein
K11101 PTCH2; patched 2
K08557 NR3C4; androgen receptor
K04079 htpG; molecular chaperone HtpG
K04079 htpG; molecular chaperone HtpG
K04079 htpG; molecular chaperone HtpG
K04079 htpG; molecular chaperone HtpG
K09487 HSP90B; heat shock protein 90kDa beta
K01351 KLK3; semenogelase [EC:3.4.21.77]
     05202 Transcriptional misregulation in cancers [PATH:ptr05202]
     05206 MicroRNAs in cancer [PATH:ptr05206]
       751933 MIR17; microRNA mir-17
       751934 MIR18A; microRNA mir-18a
       751935 MIR19A; microRNA mir-19a
       751937 MIR19B-1; microRNA mir-19b-1
       751950 MIR19B-2; microRNA mir-19b-2
       751936 MIR20A; microRNA mir-20a
       751938 MIR92-1; microRNA mir-92-1
       751951 MIR92-2; microRNA mir-92-2
       466142 PTEN; phosphatase and tensin homolog
       100316453 MIR221; microRNA mir-221
       101954207 MIR222; microRNA mir-222
       466947 CDKN1B; cyclin-dependent kinase inhibitor 1B (p27, Kip1)
       751889 MIR21; microRNA mir-21
       458784 TIMP3; TIMP metallopeptidase inhibitor 3
       100316420 MIRLET7A-2; microRNA let-7a-2
       100316361 MIRLET7A-1; microRNA let-7a-1
       100316421 MIRLET7F-2; microRNA let-7f-2
       100316033 MIRLET7A-3; microRNA let-7a-3
       100316306 MIRLET7B; microRNA let-7b
       100316035 MIRLET7D; microRNA let-7d
       100316036 MIRLET7E; microRNA let-7e
       100316362 MIRLET7F-1; microRNA let-7f-1
       100316307 MIRLET7G; microRNA let-7g
       100316037 MIRLET7I; microRNA let-7i
       100316034 MIRLET7C; microRNA let-7c
       473387 KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
       746968 CDK6; cyclin-dependent kinase 6
       460341 CDC25A; cell division cycle 25 homolog A (S. pombe)
       458064 CDC25B; cell division cycle 25 homolog B (S. pombe)
       746151 CDC25C; cell division cycle 25 homolog C (S. pombe) 
       744431 HMGA2; high mobility group AT-hook 2
       751907 MIR107; microRNA mir-107
       751931 MIR15A; microRNA mir-15a
       751870 MIR15B; microRNA mir-15b
       100316108 MIR16-2; microRNA mir-16-2
       751932 MIR16-1; microRNA mir-16-1
       747688 CCND1; cyclin D1
       747123 CCND2; cyclin D2
       464292 CCNE2; cyclin E2
       455914 CCNE1; cyclin E1
       100316068 MIR126; microRNA mir-126
       470146 CRKL; v-crk sarcoma virus CT10 oncogene homolog (avian)-like
       747142 CRK; v-crk sarcoma virus CT10 oncogene homolog (avian)
       100316308 MIR1-1; microRNA mir-1-1
       100316045 MIR1-2; microRNA mir-1-2
       462656 PIM1; pim-1 oncogene
       463671 MET; met proto-oncogene (hepatocyte growth factor receptor) 
       751893 MIR29A; microRNA mir-29a
       751903 MIR29B-1; microRNA mir-29b-1
       751904 MIR29B-2; microRNA mir-29b-2
       100316129 MIR29C; microRNA mir-29c
       739139 DNMT3A; DNA (cytosine-5-)-methyltransferase 3 alpha
       458174 DNMT3B; DNA (cytosine-5-)-methyltransferase 3 beta
       751875 MIR133A-1; microRNA mir-133a-1
       100316373 MIR133A-2; microRNA mir-133a-2
       100316097 MIR133B; microRNA mir-133b
       457274 MCL1; myeloid cell leukemia sequence 1 (BCL2-related)
       100611631 BCL2L2; BCL2-like 2
       751880 MIR145; microRNA mir-145
       463415 EGFR; epidermal growth factor receptor
       101954243 MIR200C; microRNA mir-200c
       100316374 MIR141-1; microRNA mir-141-1
       457742 TGFB2; transforming growth factor, beta 2
       751947 MIR183; microRNA mir-183
       463100 EZR; ezrin
       100316067 MIR125A; microRNA mir-125a
       751873 MIR125B-1; microRNA mir-125b-1
       751882 MIR125B-2; microRNA mir-125b-2
       450735 PDCD4; programmed cell death 4 (neoplastic transformation inhibitor)
       751878 MIR143; microRNA mir-143
       100316449 MIR192; microRNA mir-192
       751939 MIR194; microRNA mir-194
       467891 CREBBP; CREB binding protein
       458862 EP300; E1A binding protein p300 
       751940 MIR215; microRNA mir-215
       751892 MIR28; microRNA mir-28
       100316135 MIR30E; microRNA mir-30e
       751928 MIR30D; microRNA mir-30d
       751894 MIR30A; microRNA mir-30a
       751872 MIR30B; microRNA mir-30b
       100316134 MIR30C-1; microRNA mir-30c-1
       751927 MIR30C-2; microRNA mir-30c-2
       453495 TPM1; tropomyosin 1 (alpha)
       452616 SPRY2; sprouty homolog 2 (Drosophila)
       738409 BCL2; B-cell CLL/lymphoma 2
       468566 SERPINB5; serpin peptidase inhibitor, clade B (ovalbumin), member 5
       100316447 MIR155; microRNA mir-155
       100316118 MIR203; microRNA mir-203
       751917 MIR205; microRNA mir-205
       459644 ZEB2; zinc finger E-box binding homeobox 2
       450387 ZEB1; zinc finger E-box binding homeobox 1
       100188950 ST14; suppression of tumorigenicity 14 (colon carcinoma) 
       459163 CYP1B1; cytochrome P450 1B1
       751895 MIR31; microRNA mir-31
       751900 MIR99A; microRNA mir-99a
       751901 MIR100; microRNA mir-100
       457945 MTOR; mechanistic target of rapamycin (serine/threonine kinase)
       454949 RPTOR; regulatory associated protein of MTOR, complex 1
       746729 1
       454636 ERBB2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
       451980 ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
       464802 ABL1; c-abl oncogene 1, non-receptor tyrosine kinase
       460930 TP63; tumor protein p63
       100316383 MIR375; microRNA mir-375
       100316295 MIR602; microRNA mir-602
       744944 RASSF1; Ras association (RalGDS/AF-6) domain family member 1
       100316040 MIR10B; microRNA mir-10b
       739607 HOXD10; homeobox D10
       450520 DDIT4; DNA-damage-inducible transcript 4
       453323 BMF; Bcl2 modifying factor
       751924 MIR224; microRNA mir-224
       100609406 PAK4; p21 protein (Cdc42/Rac)-activated kinase 4
       458294 MMP9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
       100316473 MIR494; microRNA mir-494
       751946 MIR25; microRNA mir-25
       751911 MIR34A; microRNA mir-34a
       751948 MIR96; microRNA mir-96
       100316422 MIR10A; microRNA mir-10a
       751941 MIR23A; microRNA mir-23a
       751871 MIR23B; microRNA mir-23b
       101954218 MIR23C; microRNA mir-23c
       100316050 MIR122; microRNA mir-122
       452516 SLC7A1; solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
       462243 CCNG1; cyclin G1
       100316521 MIR150; microRNA mir-150
       751923 MIR223; microRNA mir-223
       456650 STMN1; stathmin 1
       454682 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor)
       464393 MYC; v-myc myelocytomatosis viral oncogene homolog (avian)
       461669 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       466302 HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog
       742713 NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog
       751891 MIR26A-1; microRNA mir-26a-1
       100316126 MIR26A-2; microRNA mir-26a-2
       100316127 MIR26B; microRNA mir-26b
       100316446 MIR152; microRNA mir-152
       455696 DNMT1; DNA (cytosine-5-)-methyltransferase 1
       100316099 MIR135B; microRNA mir-135b
       751876 MIR135A-2; microRNA mir-135a-2
       100316098 MIR135A-1; microRNA mir-135a-1
       461999 APC; adenomatous polyposis coli
       455551 APC2; adenomatosis polyposis coli 2
       459985 IRS1; insulin receptor substrate 1
       454499 MAPK7; mitogen-activated protein kinase 7
       100316540 MIR200A; microRNA mir-200a
       464554 HNRNPK; heterogeneous nuclear ribonucleoprotein K
       465092 RECK; reversion-inducing-cysteine-rich protein with kazal motifs
       100316320 MIR137; microRNA mir-137
       100316077 MIR128-2; microRNA mir-128-2
       751874 MIR128-1; microRNA mir-128-1
       471865 E2F3; E2F transcription factor 3
       100316267 MIR7-1; microRNA mir-7-1
       751910 MIR7-3; microRNA mir-7-3
       100316503 MIR7-2; microRNA mir-7-2
       452657 IRS2; insulin receptor substrate 2
       100316140 MIR326; microRNA mir-326
       462587 NOTCH4; notch 4
       457173 NOTCH2; notch 2
       464865 NOTCH1; notch 1
       455792 NOTCH3; notch 3
       463685 BMI1; BMI1 polycomb ring finger oncogene
       736264 BMI1; BMI1 polycomb ring finger oncogene
       466023 BMI1; BMI1 polycomb ring finger oncogene
       100316413 MIR146A; microRNA mir-146a
       736322 MMP16; matrix metallopeptidase 16 (membrane-inserted)
       751912 MIR181A-2; microRNA mir-181a-2
       751929 MIR181A-1; microRNA mir-181a-1
       100316321 MIR181B-2; microRNA mir-181b-2
       751930 MIR181B-1; microRNA mir-181b-1
       751913 MIR181C; microRNA mir-181c
       100316375 MIR181D; microRNA mir-181d
       451530 ATM; ataxia telangiectasia mutated
       737070 SOCS1; suppressor of cytokine signaling 1
       100316291 MIR373; microRNA mir-373
       100316479 MIR520A; microRNA mir-520a
       100316341 MIR520H; microRNA mir-520h
       100316480 MIR520G; microRNA mir-520g
       451122 CD44; CD44 molecule (Indian blood group)
       751905 MIR103-1; microRNA mir-103-1
       100316039 MIR103-2; microRNA mir-103-2
       453137 DICER1; dicer 1, ribonuclease type III
       472726 FZD3; frizzled family receptor 3
       451958 ITGA5; integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
       466776 RDX; radixin
       461014 RHOA; ras homolog family member A
       738078 PLAU; plasminogen activator, urokinase
       462616 BAK1; BCL2-antagonist/killer 1
       464332 ZFPM2; zinc finger protein, multitype 2
       468295 ITGB3; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
       749975 UBE2I; ubiquitin-conjugating enzyme E2I
       100316143 MIR335; microRNA mir-335
       742736 TNC; tenascin C
       469593 TNN; tenascin N
       469594 TNR; tenascin R
       462578 TNXB; tenascin-X-like
       100316451 MIR206; microRNA mir-206
       100316171 MIR451; microRNA mir-451
       463516 ABCB1; ATP-binding cassette, sub-family B (MDR/TAP), member 1
       100316147 MIR345; microRNA mir-345
       453952 ABCC1; ATP-binding cassette, sub-family C (CFTR/MRP), member 1
       449497 BRCA1; breast cancer 1, early onset
       751944 MIR106B; microRNA mir-106b
       747442 CDKN1A; cyclin-dependent kinase inhibitor 1A (p21, Cip1)
       100316324 MIR210; microRNA mir-210
       453319 THBS1; thrombospondin 1
       455198 IGF2BP1; insulin-like growth factor 2 mRNA binding protein 1
       460252 TRIM71; tripartite motif containing 71, E3 ubiquitin protein ligase
       751881 MIR9-2; microRNA mir-9-2
       100316404 MIR9-1; microRNA mir-9-1
       461406 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       751915 MIR199A-2; microRNA mir-199a-2
       472749 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       454832 PRKCA; protein kinase C, alpha
       456276 PRKCG; protein kinase C, gamma
       453993 PRKCB; protein kinase C, beta
       737245 GRB2; growth factor receptor-bound protein 2
       461067 FGFR3; fibroblast growth factor receptor 3
       739162 RPS6KA5; ribosomal protein S6 kinase, 90kDa, polypeptide 5
       455214 TP53; tumor protein p53
       742141 MDM2; Mdm2, p53 E3 ubiquitin protein ligase homolog (mouse)
       457658 MDM4; Mdm4 p53 binding protein homolog (mouse)
       461318 PDGFRA; platelet-derived growth factor receptor, alpha polypeptide
       458253 PLCG1; phospholipase C, gamma 1
       454268 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific)
       100316038 MIR101-2; microRNA mir-101-2
       751902 MIR101-1; microRNA mir-101-1
       460182 RAF1; v-raf-1 murine leukemia viral oncogene homolog 1
       100316323 MIR195; microRNA mir-195
       450188 MAP2K1; mitogen-activated protein kinase kinase 1 
       456390 MAP2K2; mitogen-activated protein kinase kinase 2
       100611792 dual specificity mitogen-activated protein kinase kinase 2-like
       459171 SOS1; son of sevenless homolog 1 (Drosophila)
       452897 SOS2; son of sevenless homolog 2 (Drosophila)
       457351 SHC1; SHC (Src homology 2 domain containing) transforming protein 1
       740202 PDGFA; platelet-derived growth factor alpha polypeptide
       100316082 MIR129-1; microRNA mir-129-1
       100316083 MIR129-2; microRNA mir-129-2
       453414 SHC4; SHC (Src homology 2 domain containing) family, member 4
       458844 PDGFB; platelet-derived growth factor beta polypeptide
       462188 PDGFRB; platelet-derived growth factor receptor, beta polypeptide
       465021 CDKN2A; cyclin-dependent kinase inhibitor 2A
       458184 E2F1; E2F transcription factor 1
       469153 E2F2; E2F transcription factor 2
       751896 MIR32; microRNA mir-32
       459487 BCL2L11; BCL2-like 11 (apoptosis facilitator)
       742020 MARCKS; myristoylated alanine-rich protein kinase C substrate
       459885 BMPR2; bone morphogenetic protein receptor, type II (serine/threonine kinase)
       100316334 MIR449A; microRNA mir-449a
       745437 EZH2; enhancer of zeste homolog 2 (Drosophila)
       470606 GLS; glutaminase
       451998 GLS2; glutaminase 2 (liver, mitochondrial)
       466088 SIRT1; sirtuin 1
       468297 WNT3; wingless-type MMTV integration site family, member 3
       100615247 WNT3A; wingless-type MMTV integration site family, member 3A
       451310 CDCA5; cell division cycle associated 5
       453544 KIF23; kinesin family member 23
       455326 ROCK1; Rho-associated, coiled-coil containing protein kinase 1
       459203 PRKCE; protein kinase C, epsilon
       457672 SLC45A3; solute carrier family 45, member 3
       493952 VIM; vimentin
K17002 MIR17; microRNA 17
K17003 MIR18A; microRNA 18a
K17005 MIR19; microRNA 19
K17005 MIR19; microRNA 19
K17005 MIR19; microRNA 19
K17006 MIR20A; microRNA 20a
K17008 MIR92A; microRNA 92a
K17008 MIR92A; microRNA 92a
K01110 PTEN; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]
K17010 MIR221; microRNA 221
K17011 MIR222; microRNA 222
K06624 CDKN1B; cyclin-dependent kinase inhibitor 1B
K16863 MIR21; microRNA 21
K16866 TIMP3; metalloproteinase inhibitor 3
K16980 MIRLET7; microRNA let-7
K16980 MIRLET7; microRNA let-7
K16980 MIRLET7; microRNA let-7
K16980 MIRLET7; microRNA let-7
K16980 MIRLET7; microRNA let-7
K16980 MIRLET7; microRNA let-7
K16980 MIRLET7; microRNA let-7
K16980 MIRLET7; microRNA let-7
K16980 MIRLET7; microRNA let-7
K16980 MIRLET7; microRNA let-7
K17397 MIRLET7C; microRNA let-7c
K07827 KRAS; GTPase KRas
K02091 CDK6; cyclin-dependent kinase 6 [EC:2.7.11.22]
K06645 CDC25A; M-phase inducer phosphatase 1 [EC:3.1.3.48]
K05866 CDC25B; M-phase inducer phosphatase 2 [EC:3.1.3.48]
K05867 CDC25C; M-phase inducer phosphatase 3 [EC:3.1.3.48]
K09283 HMGA2; high mobility group AT-hook protein 2
K17396 MIR107; microRNA 107
K16986 MIR15A; microRNA 15a
K16987 MIR15B; microRNA 15b
K16988 MIR16; microRNA 16
K16988 MIR16; microRNA 16
K04503 CCND1; cyclin D1
K10151 CCND2; cyclin D2
K06626 CCNE; cyclin E
K06626 CCNE; cyclin E
K16978 MIR126; microRNA 126
K04438 CRK; proto-oncogene C-crk
K04438 CRK; proto-oncogene C-crk
K16972 MIR1; microRNA 1
K16972 MIR1; microRNA 1
K04702 PIM1; proto-oncogene serine/threonine-protein kinase Pim-1 [EC:2.7.11.1]
K05099 MET; proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
K16995 MIR29A; microRNA 29a
K16996 MIR29B; microRNA 29b
K16996 MIR29B; microRNA 29b
K16997 MIR29C; microRNA 29c
K17398 DNMT3A; DNA (cytosine-5)-methyltransferase 3A [EC:2.1.1.37]
K17399 DNMT3B; DNA (cytosine-5)-methyltransferase 3B [EC:2.1.1.37]
K16970 MIR133A; microRNA 133a
K16970 MIR133A; microRNA 133a
K16971 MIR133B; microRNA 133b
K02539 MCL1; myeloid leukemia cell differntiation protein MCL-1
K02163 BCLW; apoptosis regulator BCL-W
K16974 MIR145; microRNA 145
K04361 EGFR; epidermal growth factor receptor [EC:2.7.10.1]
K17017 MIR200C; microRNA 200c
K17018 MIR141; microRNA 141
K13376 TGFB2; transforming growth factor beta-2
K17116 MIR183; microRNA 183
K08007 VIL2; villin 2 (ezrin)
K16993 MIR125A; microRNA 125a
K16994 MIR125B; microRNA 125b
K16994 MIR125B; microRNA 125b
K16865 PDCD4; programmed cell death protein 4
K17023 MIR143; microRNA 143
K17131 MIR192; microRNA 192
K17371 MIR194; microRNA 194
K04498 EP300; E1A/CREB-binding protein [EC:2.3.1.48]
K04498 EP300; E1A/CREB-binding protein [EC:2.3.1.48]
K17167 MIR215; microRNA 215
K17366 MIR28; microRNA 28
K17110 MIR30A_D_E; microRNA 30a/d/e
K17110 MIR30A_D_E; microRNA 30a/d/e
K17110 MIR30A_D_E; microRNA 30a/d/e
K17111 MIR30B; microRNA 30b
K17040 MIR30C; microRNA 30c
K17040 MIR30C; microRNA 30c
K10373 TPM1; tropomyosin 1
K17383 SPRY2; protein sprouty homolog 2
K02161 BCL2; apoptosis regulator BCL-2
K10139 SERPINB5; serpin B5
K17009 MIR155; microRNA 155
K16975 MIR203; microRNA 203
K17150 MIR205; microRNA 205
K09299 ZEB1_2; zinc finger homeobox protein 1/2
K09299 ZEB1_2; zinc finger homeobox protein 1/2
K08670 ST14; suppressor of tumorigenicity protein 14 [EC:3.4.21.109]
K07410 CYP1B1; cytochrome P450, family 1, subfamily B, polypeptide 1 [EC:1.14.14.1]
K17183 MIR31; microRNA 31
K17367 MIR99A; microRNA 99a
K17041 MIR100; microRNA 100
K07203 FRAP; FKBP12-rapamycin complex-associated protein
K07204 RAPTOR; regulatory associated protein of mTOR
K07436 CYP24A1; vitamin D3 24-hydroxylase [EC:1.14.13.126]
K05083 ERBB2; receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]
K05084 ERBB3; receptor tyrosine-protein kinase erbB-3 [EC:2.7.10.1]
K06619 ABL1; abelson tyrosine-protein kinase 1 [EC:2.7.10.2]
K10149 TP63; tumor protein p63
K16976 MIR375; microRNA 375
K17379 MIR602; microRNA 602
K09850 RASSF1; Ras association domain-containing protein 1
K17393 MIR10B; microRNA 10b
K09295 HOXD10; homrobox protein Hox-D10
K08270 DDIT4; DNA-damage-inducible transcript 4
K17460 BMF; Bcl-2-modifying factor
K17042 MIR224; microRNA 224
K05734 PAK4; p21-activated kinase 4 [EC:2.7.11.1]
K01403 MMP9; matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
K17378 MIR494; microRNA 494
K17038 MIR25; microRNA 25
K16982 MIR34A; microRNA 34a
K17114 MIR96; microRNA 96
K16864 MIR10A; microRNA 10a
K17165 MIR23A; microRNA 23a
K17394 MIR23B; microRNA 23b
K17395 MIR23C; microRNA 23c
K17020 MIR122; microRNA 122
K13863 SLC7A1; solute carrier family 7 (cationic amino acid transporter), member 1
K10145 CCNG1; cyclin G1
K17024 MIR150; microRNA 150
K17001 MIR223; microRNA 223
K04381 STMN1; stathmin
K04692 STAT3; signal transducer and activator of transcription 3
K04377 MYC; Myc proto-oncogene protein
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K02833 HRAS; GTPase HRas
K07828 NRAS; GTPase NRas
K16984 MIR26A; microRNA 26a
K16984 MIR26A; microRNA 26a
K16985 MIR26B; microRNA 26b
K17370 MIR152; microRNA 152
K00558 DNMT1; DNA (cytosine-5)-methyltransferase 1 [EC:2.1.1.37]
K17144 MIR135; microRNA 135
K17144 MIR135; microRNA 135
K17144 MIR135; microRNA 135
K02085 APC; adenomatosis polyposis coli protein
K02085 APC; adenomatosis polyposis coli protein
K16172 IRS1; insulin receptor substrate 1
K04464 MAPK7; mitogen-activated protein kinase 7 [EC:2.7.11.24]
K17015 MIR200A; microRNA 200a
K12886 HNRNPK; heterogeneous nuclear ribonucleoprotein K
K17461 RECK; reversion-inducing-cysteine-rich protein with kazal motifs
K17369 MIR137; microRNA 137
K17130 MIR128; microRNA 128
K17130 MIR128; microRNA 128
K06620 E2F3; transcription factor E2F3
K17365 MIR7; microRNA 7
K17365 MIR7; microRNA 7
K17365 MIR7; microRNA 7
K07187 IRS2; insulin receptor substrate 2
K17372 MIR326; microRNA 326
K02599 NOTCH; Notch
K02599 NOTCH; Notch
K02599 NOTCH; Notch
K02599 NOTCH; Notch
K11459 PCGF4; polycomb group RING finger protein 4
K11459 PCGF4; polycomb group RING finger protein 4
K11459 PCGF4; polycomb group RING finger protein 4
K17012 MIR146A; microRNA 146a
K07996 MMP16; matrix metalloproteinase-16 (membrane-inserted) [EC:3.4.24.-]
K17025 MIR181A; microRNA 181a
K17025 MIR181A; microRNA 181a
K17026 MIR181B; microRNA 181b
K17026 MIR181B; microRNA 181b
K17027 MIR181C; microRNA 181c
K17028 MIR181D; microRNA 181d
K04728 ATM; ataxia telangiectasia mutated family protein [EC:2.7.11.1]
K04694 SOCS1; suppressor of cytokine signaling 1
K17000 MIR373; microRNA 373
K17175 MIR520; microRNA 520
K17175 MIR520; microRNA 520
K17175 MIR520; microRNA 520
K06256 CD44; CD44 antigen
K16989 MIR103; microRNA 103
K16989 MIR103; microRNA 103
K11592 DICER1; endoribonuclease Dicer [EC:3.1.26.-]
K02329 FZD3; frizzled 3
K06484 ITGA5; integrin alpha 5
K05762 RDX; radixin
K04513 RHOA; Ras homolog gene family, member A
K01348 PLAU; urokinase plasminogen activator [EC:3.4.21.73]
K14021 BAK; Bcl-2 homologous antagonist/killer
K17442 ZFPM2; zinc finger protein ZFPM2
K06493 ITGB3; integrin beta 3
K10577 UBE2I; ubiquitin-conjugating enzyme E2 I [EC:6.3.2.19]
K17033 MIR335; microRNA 335
K06252 TN; tenascin
K06252 TN; tenascin
K06252 TN; tenascin
K06252 TN; tenascin
K16973 MIR206; microRNA 206
K17172 MIR451; microRNA 451
K05658 ABCB1; ATP-binding cassette, subfamily B (MDR/TAP), member 1 [EC:3.6.3.44]
K17375 MIR345; microRNA 345
K05665 ABCC1; ATP-binding cassette, subfamily C (CFTR/MRP), member 1
K10605 BRCA1; breast cancer type 1 susceptibility protein
K17035 MIR106B; microRNA 106b
K06625 CDKN1A; cyclin-dependent kinase inhibitor 1A
K17178 MIR210; microRNA 210
K16857 THBS1; thrombospondin 1
K17391 IGF2BP1; insulin-like growth factor 2 mRNA-binding protein 1
K12035 TRIM71; tripartite motif-containing protein 71 [EC:6.3.2.19]
K16977 MIR9; microRNA 9
K16977 MIR9; microRNA 9
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K17118 MIR199A; microRNA 199a
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K04364 GRB2; growth factor receptor-binding protein 2
K05094 FGFR3; fibroblast growth factor receptor 3 [EC:2.7.10.1]
K04445 MSK1; ribosomal protein S6 kinase alpha-5 [EC:2.7.11.1]
K04451 TP53; tumor protein p53
K06643 MDM2; E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19]
K10127 MDM4; protein Mdm4
K04363 PDGFRA; platelet-derived growth factor receptor alpha [EC:2.7.10.1]
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K17129 MIR101; microRNA 101
K17129 MIR101; microRNA 101
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K17029 MIR195; microRNA 195
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K03099 SOS; son of sevenless
K03099 SOS; son of sevenless
K06279 SHC1; SHC- transforming protein 1
K04359 PDGFA; platelet-derived growth factor subunit A
K17368 MIR129; microRNA 129
K17368 MIR129; microRNA 129
K17449 SHC4; SHC- transforming protein 4
K17386 PDGFB; platelet-derived growth factor subunit B
K05089 PDGFRB; platelet-derived growth factor receptor beta [EC:2.7.10.1]
K06621 CDKN2A; cyclin-dependent kinase inhibitor 2A
K17454 E2F1; transcription factor E2F1
K09389 E2F2; transcription factor E2F2
K17039 MIR32; microRNA 32
K16341 BCL2L11; Bcl-2-like protein 11
K12561 MARCKS; myristoylated alanine-rich C-kinase substrate
K04671 BMPR2; bone morphogenetic protein receptor type-2 [EC:2.7.11.30]
K17377 MIR449A; microRNA 449a
K11430 EZH2; histone-lysine N-methyltransferase EZH2 [EC:2.1.1.43]
K01425 glsA; glutaminase [EC:3.5.1.2]
K01425 glsA; glutaminase [EC:3.5.1.2]
K11411 SIRT1; NAD-dependent deacetylase sirtuin 1 [EC:3.5.1.-]
K00312 WNT3; wingless-type MMTV integration site family, member 3
K00312 WNT3; wingless-type MMTV integration site family, member 3
K17390 CDCA5; sororin
K17387 KIF23; kinesin family member 23
K04514 ROCK1; Rho-associated protein kinase 1 [EC:2.7.11.1]
K18050 PRKCE; novel protein kinase C epsilon type [EC:2.7.11.13]
K15379 SLC45A3; solute carrier family 45, member 3
K07606 VIM; vimentin
     05205 Proteoglycans in cancer [PATH:ptr05205]
     05204 Chemical carcinogenesis [PATH:ptr05204]
       453744 cytochrome P450 1A1-like
       463582 CYP3A4; cytochrome P450, family 3, subfamily A, polypeptide 4
       737374 CYP3A5; cytochrome P450, family 3, subfamily A, polypeptide 5 
       100608616 cytochrome P450 3A7-like
       737263 CYP3A7; cytochrome P450, family 3, subfamily A, polypeptide 67
       472456 CYP3A43; cytochrome P450 subfamily IIIA polypeptide 43
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       464023 NAT1; N-acetyltransferase 1 (arylamine N-acetyltransferase)
       464024 NAT2; N-acetyltransferase 2 (arylamine N-acetyltransferase)
       735881 cytochrome P450 1A2-like
       454013 SULT1A1; sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
       739600 SULT1A4; sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4
       100616003 SULT1A2; sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2
       459163 CYP1B1; cytochrome P450 1B1
       450909 CYP2C8; cytochrome P450, family 2, subfamily C, polypeptide 8
       100616515 cytochrome P450 2C9-like
       740956 cytochrome P450 2C19-like
       457777 EPHX1; epoxide hydrolase 1, microsomal (xenobiotic)
       457279 ARNT; aryl hydrocarbon receptor nuclear translocator
       457477 MGST3; microsomal glutathione S-transferase 3
       470264 GSTT1; glutathione S-transferase theta 1
       462769 GSTA2; glutathione S-transferase alpha 2
       462770 GSTA3; glutathione S-transferase alpha 3
       462771 GSTA4; glutathione S-transferase alpha 4
       737085 MGST2; microsomal glutathione S-transferase 2
       457128 GSTM3; glutathione S-transferase mu 3 (brain)
       745685 GSTM5; glutathione S-transferase mu 5
       458962 GSTT2; glutathione S-transferase theta 2
       450720 GSTO2; glutathione S-transferase omega 2
       745954 GSTP1; glutathione S-transferase pi 1
       450719 GSTO1; glutathione S-transferase omega 1 
       741887 GSTA5; glutathione S-transferase alpha 5
       100611543 GSTA1; glutathione S-transferase alpha 1
       457094 GSTM4; glutathione S-transferase mu 4
       745723 GSTM1; glutathione S-transferase mu 1
       740580 MGST1; microsomal glutathione S-transferase 1 
       463802 GSTK1; glutathione S-transferase kappa 1
       456409 SULT2A1; sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
       467639 CHRNA7; cholinergic receptor, nicotinic, alpha 7 (neuronal)
       473983 CBR1; carbonyl reductase 1
       457698 HSD11B1; hydroxysteroid (11-beta) dehydrogenase 1
       461285 UGT2B4; UDP glucuronosyltransferase 2 family, polypeptide B4
       461289 UGT2B15; UDP glucuronosyltransferase 2 family, polypeptide B15
       471220 UGT2A3; UDP glucuronosyltransferase 2 family, polypeptide A3
       471218 UGT2B7; UDP glucuronosyltransferase 2 family, polypeptide B7
       739942 UGT1A6; UDP glucuronosyltransferase 1 family, polypeptide A6
       742890 UGT2A1; UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus
       471217 UGT2B28; UDP glucuronosyltransferase 2 family, polypeptide B28
       100611992 UGT2B11; UDP glucuronosyltransferase 2 family, polypeptide B11
       471219 UGT2B28; UDP glucuronosyltransferase 2 family, polypeptide B28
       743607 UGT2B17; UDP glucuronosyltransferase 2 family, polypeptide B17
       461287 UGT2B10; UDP glucuronosyltransferase 2 family, polypeptide B10
       450857 cytochrome P450 2E1-like
       466685 ALDH3B1; aldehyde dehydrogenase 3 family, member B1
       453686 ALDH1A3; aldehyde dehydrogenase 1 family, member A3
       468186 ALDH3A1; aldehyde dehydrogenase 3 family, member A1
       744064 ADH1A; alcohol dehydrogenase 1A (class I), alpha polypeptide
       461396 ADH1B; alcohol dehydrogenase 1B (class I), beta polypeptide 
       744176 ADH1C; alcohol dehydrogenase 1C (class I), gamma polypeptide
       471257 ADH7; alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
       461394 ADH4; alcohol dehydrogenase 4 (class II), pi polypeptide
       461395 ADH6; alcohol dehydrogenase 6 (class V)
       743928 ADH5; alcohol dehydrogenase 5 (class III), chi polypeptide
       456999 CCBL2; cysteine conjugate-beta lyase 2
       473069 CCBL1; cysteine conjugate-beta lyase, cytoplasmic 
K07408 CYP1A1; cytochrome P450, family 1, subfamily A, polypeptide 1 [EC:1.14.14.1]
K17689 CYP3A4; cytochrome P450, family 3, subfamily A, polypeptide 4 [EC:1.14.13.32 1.14.13.67 1.14.13.97 1.14.13.157 1.14.13.-]
K17690 CYP3A5; cytochrome P450, family 3, subfamily A, polypeptide 5 [EC:1.14.14.1]
K17691 CYP3A7; cytochrome P450, family 3, subfamily A, polypeptide 7 [EC:1.14.14.1]
K17691 CYP3A7; cytochrome P450, family 3, subfamily A, polypeptide 7 [EC:1.14.14.1]
K17692 CYP3A43; cytochrome P450, family 3, subfamily A, polypeptide 43 [EC:1.14.14.1]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K00622 nat; arylamine N-acetyltransferase [EC:2.3.1.5]
K00622 nat; arylamine N-acetyltransferase [EC:2.3.1.5]
K07409 CYP1A2; cytochrome P450, family 1, subfamily A, polypeptide 2 [EC:1.14.14.1]
K01014 SULT1A; aryl sulfotransferase [EC:2.8.2.1]
K01014 SULT1A; aryl sulfotransferase [EC:2.8.2.1]
K01014 SULT1A; aryl sulfotransferase [EC:2.8.2.1]
K07410 CYP1B1; cytochrome P450, family 1, subfamily B, polypeptide 1 [EC:1.14.14.1]
K17718 CYP2C8; cytochrome P450, family 2, subfamily C, polypeptide 8 [EC:1.14.14.1]
K17719 CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9 [EC:1.14.13.48 1.14.13.49 1.14.13.80 1.14.13.-]
K17721 CYP2C19; cytochrome P450, family 2, subfamily C, polypeptide 19 [EC:1.14.13.48 1.14.13.49 1.14.13.80 1.14.13.-]
K01253 EPHX1; microsomal epoxide hydrolase [EC:3.3.2.9]
K09097 ARNT; aryl hydrocarbon receptor nuclear translocator
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K00799 GST; glutathione S-transferase [EC:2.5.1.18]
K13299 GSTK1; glutathione S-transferase kappa 1 [EC:2.5.1.18]
K11822 SULT2A1; bile-salt sulfotransferase [EC:2.8.2.14]
K04809 CHRNA7; nicotinic acetylcholine receptor alpha-7
K00079 CBR1; carbonyl reductase 1 [EC:1.1.1.184 1.1.1.189 1.1.1.197]
K15680 HSD11B1; corticosteroid 11-beta-dehydrogenase isozyme 1 [EC:1.1.1.146]
K00699 UGT; glucuronosyltransferase [EC:2.4.1.17]
K00699 UGT; glucuronosyltransferase [EC:2.4.1.17]
K00699 UGT; glucuronosyltransferase [EC:2.4.1.17]
K00699 UGT; glucuronosyltransferase [EC:2.4.1.17]
K00699 UGT; glucuronosyltransferase [EC:2.4.1.17]
K00699 UGT; glucuronosyltransferase [EC:2.4.1.17]
K00699 UGT; glucuronosyltransferase [EC:2.4.1.17]
K00699 UGT; glucuronosyltransferase [EC:2.4.1.17]
K00699 UGT; glucuronosyltransferase [EC:2.4.1.17]
K00699 UGT; glucuronosyltransferase [EC:2.4.1.17]
K00699 UGT; glucuronosyltransferase [EC:2.4.1.17]
K07415 CYP2E1; cytochrome P450, family 2, subfamily E, polypeptide 1 [EC:1.14.13.-]
K00129 E1.2.1.5; aldehyde dehydrogenase (NAD(P)+) [EC:1.2.1.5]
K00129 E1.2.1.5; aldehyde dehydrogenase (NAD(P)+) [EC:1.2.1.5]
K00129 E1.2.1.5; aldehyde dehydrogenase (NAD(P)+) [EC:1.2.1.5]
K13951 ADH1_7; alcohol dehydrogenase 1/7 [EC:1.1.1.1]
K13951 ADH1_7; alcohol dehydrogenase 1/7 [EC:1.1.1.1]
K13951 ADH1_7; alcohol dehydrogenase 1/7 [EC:1.1.1.1]
K13951 ADH1_7; alcohol dehydrogenase 1/7 [EC:1.1.1.1]
K13980 ADH4; alcohol dehydrogenase 4 [EC:1.1.1.1]
K13952 ADH6; alcohol dehydrogenase 6 [EC:1.1.1.1]
K00121 frmA; S-(hydroxymethyl)glutathione dehydrogenase / alcohol dehydrogenase [EC:1.1.1.284 1.1.1.1]
K00816 CCBL; kynurenine---oxoglutarate transaminase / cysteine-S-conjugate beta-lyase / glutamine---phenylpyruvate transaminase [EC:2.6.1.7 4.4.1.13 2.6.1.64]
K00816 CCBL; kynurenine---oxoglutarate transaminase / cysteine-S-conjugate beta-lyase / glutamine---phenylpyruvate transaminase [EC:2.6.1.7 4.4.1.13 2.6.1.64]
     05203 Viral carcinogenesis [PATH:ptr05203]
     05210 Colorectal cancer [PATH:ptr05210]
     05212 Pancreatic cancer [PATH:ptr05212]
     05214 Glioma [PATH:ptr05214]
     05216 Thyroid cancer [PATH:ptr05216]
     05221 Acute myeloid leukemia [PATH:ptr05221]
     05220 Chronic myeloid leukemia [PATH:ptr05220]
     05217 Basal cell carcinoma [PATH:ptr05217]
     05218 Melanoma [PATH:ptr05218]
     05211 Renal cell carcinoma [PATH:ptr05211]
     05219 Bladder cancer [PATH:ptr05219]
     05215 Prostate cancer [PATH:ptr05215]
     05213 Endometrial cancer [PATH:ptr05213]
     05222 Small cell lung cancer [PATH:ptr05222]
       747260 FHIT; fragile histidine triad
       745516 RARB; retinoic acid receptor, beta
       464834 RXRA; retinoid X receptor, alpha
       462601 RXRB; retinoid X receptor, beta
       457476 RXRG; retinoid X receptor, gamma
       455214 TP53; tumor protein p53
       738409 BCL2; B-cell CLL/lymphoma 2
       742456 cytochrome c-like
       738805 cytochrome c-like
       743378 cytochrome c-like
       741158 cytochrome c-like
       735325 cytochrome c-like
       737013 cytochrome c-like
       745019 cytochrome c-like
       464105 cytochrome c-like
       744779 CYCS; cytochrome c, somatic
       100613341 cytochrome c 2-like
       100610744 cytochrome c-like
       100613249 cytochrome c-like
       452153 APAF1; apoptotic peptidase activating factor 1
       456457 CASP9; caspase 9, apoptosis-related cysteine peptidase
       464393 MYC; v-myc myelocytomatosis viral oncogene homolog (avian)
       452972 MAX; MYC associated factor X
       455403 PIAS2; protein inhibitor of activated STAT, 2
       473204 CDKN2B; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
       452025 CDK4; cyclin-dependent kinase 4
       746968 CDK6; cyclin-dependent kinase 6
       747688 CCND1; cyclin D1
       464582 CKS2; CDC28 protein kinase regulatory subunit 2
       100608937 CKS1B; cyclin-dependent kinases regulatory subunit 1
       471570 SKP2; S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
       467032 CDK2; cyclin-dependent kinase 2
       464292 CCNE2; cyclin E2
       455914 CCNE1; cyclin E1
       452715 RB1; retinoblastoma 1
       458184 E2F1; E2F transcription factor 1
       469153 E2F2; E2F transcription factor 2
       471865 E2F3; E2F transcription factor 3
       452659 COL4A1; collagen, type IV, alpha 1
       459986 COL4A4; collagen, type IV, alpha 4
       465804 COL4A6; collagen, type IV, alpha 6
       452661 COL4A2; collagen, type IV, alpha 2
       459988 COL4A3; collagen, type IV, alpha 3 (Goodpasture antigen)
       465805 COL4A5; collagen, type IV, alpha 5
       455302 LAMA1; laminin, alpha 1
       472122 LAMA2; laminin, alpha 2
       455339 LAMA3; laminin, alpha 3
       458387 LAMA5; laminin, alpha 5
       462946 LAMA4; laminin, alpha 4
       463656 LAMB1; laminin, beta 1
       460365 LAMB2; laminin, beta 2 (laminin S)
       469668 LAMB3; laminin, beta 3
       463657 LAMB4; laminin, beta 4
       457570 LAMC1; laminin, gamma 1 (formerly LAMB2)
       457571 LAMC2; laminin, gamma 2
       100611162 LAMC3; laminin, gamma 3
       464805 laminin subunit gamma-3-like
       459926 FN1; fibronectin 1
       471550 ITGA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
       454730 ITGA2B; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
       455111 ITGA3; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
       459742 ITGA6; integrin, alpha 6
       459807 ITGAV; integrin, alpha V
       450396 ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
       464422 PTK2; PTK2 protein tyrosine kinase 2
       463649 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
       460858 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
       457922 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
       471079 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
       456565 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       461836 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       455085 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       455855 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       466142 PTEN; phosphatase and tensin homolog
       456035 AKT2; v-akt murine thymoma viral oncogene homolog 2
       740898 AKT1; v-akt murine thymoma viral oncogene homolog 1
       100609583 AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) 
       450673 CHUK; conserved helix-loop-helix ubiquitous kinase 
       472749 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
       100610002 NF-kappa-B essential modulator-like
       467426 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       461406 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       466665 RELA; v-rel reticuloendotheliosis viral oncogene homolog A (avian)
       451508 BIRC2; baculoviral IAP repeat containing 2
       451507 BIRC3; baculoviral IAP repeat containing 3
       473765 XIAP; X-linked inhibitor of apoptosis
       746160 BIRC7; baculoviral IAP repeat containing 7
       450113 BIRC8; baculoviral IAP repeat containing 8
       458156 BCL2L1; BCL2-like 1
       743748 TRAF1; TNF receptor-associated factor 1
       464876 TRAF2; TNF receptor-associated factor 2
       453178 TRAF3; TNF receptor-associated factor 3
       454534 TRAF4; TNF receptor-associated factor 4
       457711 TRAF5; TNF receptor-associated factor 5
       451702 TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       455026 NOS2; nitric oxide synthase 2, inducible
K01522 FHIT; bis(5'-adenosyl)-triphosphatase [EC:3.6.1.29]
K08528 NR1B2; retinoic acid receptor beta
K08524 NR2B1; retinoid X receptor alpha
K08525 NR2B2; retinoid X receptor beta
K08526 NR2B3; retinoid X receptor gamma
K04451 TP53; tumor protein p53
K02161 BCL2; apoptosis regulator BCL-2
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K08738 CYC; cytochrome c
K02084 APAF1; apoptotic protease-activating factor
K04399 CASP9; caspase 9 [EC:3.4.22.62]
K04377 MYC; Myc proto-oncogene protein
K04453 MAX; Max protein
K16063 PIAS2; E3 SUMO-protein ligase PIAS2 [EC:6.3.2.-]
K04685 CDKN2B; cyclin-dependent kinase inhibitor 2B
K02089 CDK4; cyclin-dependent kinase 4 [EC:2.7.11.22]
K02091 CDK6; cyclin-dependent kinase 6 [EC:2.7.11.22]
K04503 CCND1; cyclin D1
K02219 CKS1; cyclin-dependent kinase regulatory subunit CKS1
K02219 CKS1; cyclin-dependent kinase regulatory subunit CKS1
K03875 SKP2; F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2)
K02206 CDK2; cyclin-dependent kinase 2 [EC:2.7.11.22]
K06626 CCNE; cyclin E
K06626 CCNE; cyclin E
K06618 RB1; retinoblastoma-associated protein
K17454 E2F1; transcription factor E2F1
K09389 E2F2; transcription factor E2F2
K06620 E2F3; transcription factor E2F3
K06237 COL4A; collagen, type IV, alpha
K06237 COL4A; collagen, type IV, alpha
K06237 COL4A; collagen, type IV, alpha
K06237 COL4A; collagen, type IV, alpha
K06237 COL4A; collagen, type IV, alpha
K06237 COL4A; collagen, type IV, alpha
K05637 LAMA1_2; laminin, alpha 1/2
K05637 LAMA1_2; laminin, alpha 1/2
K06240 LAMA3_5; laminin, alpha 3/5
K06240 LAMA3_5; laminin, alpha 3/5
K06241 LAMA4; laminin, alpha 4
K05636 LAMB1; laminin, beta 1
K06243 LAMB2; laminin, beta 2
K06244 LAMB3; laminin, beta 3
K06245 LAMB4; laminin, beta 4
K05635 LAMC1; laminin, gamma 1
K06246 LAMC2; laminin, gamma 2
K06247 LAMC3; laminin, gamma 3
K06247 LAMC3; laminin, gamma 3
K05717 FN1; fibronectin 1
K06481 ITGA2; integrin alpha 2
K06476 ITGA2B; integrin alpha 2B
K06482 ITGA3; integrin alpha 3
K06485 ITGA6; integrin alpha 6
K06487 ITGAV; integrin alpha V
K05719 ITGB1; integrin beta 1
K05725 PTK2; focal adhesion kinase 1 [EC:2.7.10.2]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K01110 PTEN; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K04725 XIAP; E3 ubiquitin-protein ligase XIAP
K16061 BIRC7_8; baculoviral IAP repeat-containing protein 7/8
K16061 BIRC7_8; baculoviral IAP repeat-containing protein 7/8
K04570 BCL2L1; BCL2-like 1 (apoptosis regulator Bcl-X)
K03172 TRAF1; TNF receptor-associated factor 1
K03173 TRAF2; TNF receptor-associated factor 2
K03174 TRAF3; TNF receptor-associated factor 3
K09848 TRAF4; TNF receptor-associated factor 4
K09849 TRAF5; TNF receptor-associated factor 5
K03175 TRAF6; TNF receptor-associated factor 6
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K13241 NOS2; nitric-oxide synthase, inducible [EC:1.14.13.39]
     05223 Non-small cell lung cancer [PATH:ptr05223]
 
   Immune diseases
 
   Neurodegenerative diseases
 
   Substance dependence
 
   Cardiovascular diseases
 
   Endocrine and metabolic diseases
 
   Infectious diseases
     05110 Vibrio cholerae infection
     05111 Vibrio cholerae pathogenic cycle
     05120 Epithelial cell signaling in Helicobacter pylori infection
     05130 Pathogenic Escherichia coli infection
     05132 Salmonella infection [PATH:ptr05132]
     05131 Shigellosis
     05133 Pertussis [PATH:ptr05133]
     05134 Legionellosis [PATH:ptr05134]
     05150 Staphylococcus aureus infection [PATH:ptr05150]
     05152 Tuberculosis [PATH:ptr05152]
     05100 Bacterial invasion of epithelial cells [PATH:ptr05100]
     05166 HTLV-I infection [PATH:ptr05166]
     05162 Measles [PATH:ptr05162]
     05164 Influenza A [PATH:ptr05164]
     05161 Hepatitis B [PATH:ptr05161]
     05160 Hepatitis C [PATH:ptr05160]
     05168 Herpes simplex infection [PATH:ptr05168]
     05169 Epstein-Barr virus infection [PATH:ptr05169]
     05146 Amoebiasis [PATH:ptr05146]
     05144 Malaria [PATH:ptr05144]
     05145 Toxoplasmosis [PATH:ptr05145]
     05140 Leishmaniasis [PATH:ptr05140]
       471325 TLR2; toll-like receptor 2
       743242 TLR4; toll-like receptor 4
       460269 MYD88; myeloid differentiation primary response gene (88)
       465935 IRAK1; interleukin-1 receptor-associated kinase 1
       466962 IRAK4; interleukin-1 receptor-associated kinase 4
       451702 TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase
       462888 MAP3K7; mitogen-activated protein kinase kinase kinase 7
       458845 TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1
       463057 TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2
       456014 NFKBIB; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
       467426 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       461406 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       466665 RELA; v-rel reticuloendotheliosis viral oncogene homolog A (avian)
       470485 IL1A; interleukin 1, alpha
       450200 IL1B; interleukin 1, beta
       460816 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)
       471723 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)
       494186 TNF; tumor necrosis factor
       449565 IL4; interleukin 4
       455026 NOS2; nitric oxide synthase 2, inducible
       469657 IL10; interleukin 10
       456060 TGFB1; transforming growth factor, beta 1
       457742 TGFB2; transforming growth factor, beta 2
       453054 TGFB3; transforming growth factor, beta 3
       455644 C3; complement component 3
       449643 CR1; complement component (3b/4b) receptor 1 (Knops blood group)
       454069 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit)
       458607 ITGB2; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
       745068 uncharacterized LOC745068
       457259 FCGR1A; Fc fragment of IgG, high affinity Ia, receptor (CD64)
       450194 FCGR2A; Fc fragment of IgG, low affinity IIa, receptor (CD32)
       748765 FCGR2C; Fc fragment of IgG, low affinity IIc, receptor for (CD32)
       457457 FCGR3A; Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
       745350 FCGR3B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
       470596 ITGA4; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
       450396 ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       743307 NCF1; neutrophil cytosolic factor 1
       457573 NCF2; neutrophil cytosolic factor 2
       741196 NCF4; neutrophil cytosolic factor 4, 40kDa
       468068 CYBA; cytochrome b-245 light chain-like
       454037 MAPK3; mitogen-activated protein kinase 3
       458680 MAPK1; mitogen-activated protein kinase 1
       473591 ELK1; ELK1, member of ETS oncogene family
       453047 FOS; FBJ murine osteosarcoma viral oncogene homolog
       456893 JUN; jun proto-oncogene
       450161 MAPK14; mitogen-activated protein kinase 14 
       462644 MAPK13; mitogen-activated protein kinase 13 
       747077 MAPK12; mitogen-activated protein kinase 12
       449517 IFNG; interferon, gamma
       747276 IFNGR1; interferon gamma receptor 1
       470077 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1)
       743373 JAK1; Janus kinase 1
       464979 JAK2; Janus kinase 2
       459834 STAT1; signal transducer and activator of transcription 1, 91kDa
       449592 PATR-DMB; major histocompatibility complex, class II, DM beta
       471974 PATR-DQA1; major histocompatibility complex, class II, DQ alpha 1
       471976 PATR-DQA2; major histocompatibility complex, class II, DQ alpha 2
       471977 PATR-DOB; major histocompatibility complex, class II, DO beta
       471979 HLA class II histocompatibility antigen
       462591 PATR-DRA; major histocompatibility complex, class II, DR alpha
       462594 PATR-DQB1; major histocompatibility complex, class II, DQ beta 1
       462598 PATR-DPA1; major histocompatibility complex, class II, DP alpha 1
       462599 PATR-DPB1; major histocompatibility complex, class II, DP beta 1
       462592 PATR-DRB5; major histocompatibility complex, class II, DR beta 5
       100616520 HLA class II histocompatibility antigen
       100608816 MAMU-DMA; HLA class II histocompatibility antigen, DM alpha chain-like
       745609 MARCKSL1; MARCKS-like 1
       748032 PTPN6; protein tyrosine phosphatase, non-receptor type 6
K10159 TLR2; toll-like receptor 2
K10160 TLR4; toll-like receptor 4
K04729 MYD88; myeloid differentiation primary response protein MyD88
K04730 IRAK1; interleukin-1 receptor-associated kinase 1 [EC:2.7.11.1]
K04733 IRAK4; interleukin-1 receptor-associated kinase 4 [EC:2.7.11.1]
K03175 TRAF6; TNF receptor-associated factor 6
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04403 MAP3K7IP1; TAK1-binding protein 1
K04404 MAP3K7IP2; TAK1-binding protein 2
K02581 NFKBIB; NF-kappa-B inhibitor beta
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K03156 TNFA; tumor necrosis factor superfamily, member 2
K05430 IL4; interleukin 4
K13241 NOS2; nitric-oxide synthase, inducible [EC:1.14.13.39]
K05443 IL10; interleukin 10
K13375 TGFB1; transforming growth factor beta-1
K13376 TGFB2; transforming growth factor beta-2
K13377 TGFB3; transforming growth factor beta-3
K03990 C3; complement component 3
K04011 CR1; complement component (3b/4b) receptor 1
K06461 ITGAM; integrin alpha M
K06464 ITGB2; integrin beta 2
K06856 IGH; immunoglobulin heavy chain
K06498 FCGR1A; high affinity immunoglobulin gamma Fc receptor I
K06472 FCGR2A; low affinity immunoglobulin gamma Fc region receptor II-a
K16824 FCGR2C; low affinity immunoglobulin gamma Fc region receptor II-c
K06463 FCGR3; low affinity immunoglobulin gamma Fc region receptor III
K06463 FCGR3; low affinity immunoglobulin gamma Fc region receptor III
K06483 ITGA4; integrin alpha 4
K05719 ITGB1; integrin beta 1
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K08011 NCF1; neutrophil cytosolic factor 1
K08010 NCF2; neutrophil cytosolic factor 2
K08012 NCF4; neutrophil cytosolic factor 4
K08009 CYBA; cytochrome b-245, alpha polypeptide
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04375 ELK1; ETS domain-containing protein Elk-1
K04379 FOS; proto-oncogene protein c-fos
K04448 JUN; transcription factor AP-1
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04687 IFNG; interferon gamma
K05132 IFNGR1; interferon gamma receptor 1
K05133 IFNGR2; interferon gamma receptor 2
K11217 JAK1; Janus kinase 1 [EC:2.7.10.2]
K04447 JAK2; Janus kinase 2 [EC:2.7.10.2]
K11220 STAT1; signal transducer and activator of transcription 1
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K13536 MARCKSL1; MARCKS-related protein
K05697 PTPN6; tyrosine-protein phosphatase non-receptor type 6 [EC:3.1.3.48]
     05142 Chagas disease (American trypanosomiasis) [PATH:ptr05142]
     05143 African trypanosomiasis [PATH:ptr05143]
 
   Drug resistance

[ BRITE | KEGG2 | KEGG ]
Last updated: October 1, 2014